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ABSTRACT 
 Traumatic injuries often result in infections leading to high morbidity and 
mortality. Fungal spores, the point of interest of this research, of species such as 
Mucormycetes, Scedosporium, Lomentospora, Fusarium and Candida, are ubiquitous 
in the environment.  
 Here, we have taken dual approach to investigate: 1) how two novel treatments 
- acetic acid and blue light - are effective against those fungal species, and 2) how 
highly pathogenic and antifungal resistant species of Scedosporium and 
Lomentospora interact with innate immune cells.  
 Firstly, I have demonstrated that low concentrations of acetic acid can inhibit 
spore germination as well as prevent growth of all fungal species tested. Therefore, 
acetic acid can be used as a potential preventative measure and/or treatment on 
infected wounds. Secondly, I have shown that blue light irradiation is effective against 
some, but not all fungal species, and should therefore be used with caution in a 
healthcare setting.  
 In the latter part of this thesis I characterize the Scedosporium and 
Lomentospora interaction with macrophages. Using this system, I show for the first 
time that vomocytosis and lateral transfer are two distinct events and that these 
neglected fungal pathogens may hold interesting promise as a tool for understanding 
the fungal/host interaction.  Lastly, I report on our preliminary attempts to establish a 
novel ex-vivo skin model and show that Langerhans cells within the epidermis do not 
mature nor release TNFα cytokine following infection with R. microsporus and S. 
apiospermum. 
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1. INTRODUCTION
1.1 Trauma-associated wounds
 Human skin is a protective surface, whose role is to protect the host by 
regulating microbial populations living on the skin and resisting invasion by potential 
environmental pathogens (Bowler et al., 2001) whilst preserving body fluid 
homeostasis and thermoregulation (Church et al., 2006). When this barrier is 
breached, and tissue loses its integrity, the resultant wound forms an ideal environment 
for microbial colonization and invasion. The wound can be caused by traumatic injuries 
sustained in both military and civilian environments like agricultural, motor vehicle, 
blunt crush injuries and natural disasters (Warkentien et al., 2012). Wounds can be 
divided broadly into acute or chronic classes. Acute wounds such as surgical wounds, 
burns, cuts or traumatic injuries, are a major health problem, with 11 million people 
affected, and approximately 300,000 people hospitalised yearly in the United States 
alone (Demidova-Rice et al., 2012). Chronic, non-healing wounds such as diabetic 
ulcers cost the National Health Service in the United Kingdom in 2005 - 2006 £15 -18 
million annually (Nunan et al., 2014). The wound nutritive, moist and warm 
environment provides an ideal ecosystem for various pathogens such as bacteria, 
fungi and viruses. Our immune system activates cells within minutes of the injury when 
a pathogen is recognised (Hazeldine et al., 2017). Neutrophils and macrophages are 
the first line of defense after traumatic injury. However, chronic, non-healing wounds 
are very often hypoxic, with poor blood perfusion resulting in cell death and tissue 
necrosis, further supporting microbial growth (Bowler et al., 2001). In addition, chronic 
wounds can restrict the delivery of antibiotics due to critical blood supply and adequate 
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perfusion of target tissue, making treatment extremely difficult (Nunan et al., 2014). 
Wound colonization is most commonly polymicrobial. Common aerobic pathogens 
such as Staphylococcus aureus and Pseudomonas aeruginosa are the primary cause 
of delayed healing in acute and chronic wounds (Bowler et al., 2001). However, 
anaerobes, which often die in the presence of air, such as Bacteroides, Prevotella, 
Porphyromonas, or Peptostreptococcus spp. frequently survive in wounds. However, 
it is not only bacteria that are able to survive within wounds, fungal pathogens can also. 
With many traumatic injuries occurring outdoors, fungal contamination from 
environmental sources is a serious consideration for treatment of these injuries. It is 
these fungi that infected traumatic wounds that will be the focus of this thesis.  
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Figure 1.1 Acute versus chronic wound. 
Figure adapted from Clark et al., 2007.  Left panel presents tissue injury followed by 
blood clotting, platelet aggregation and migration of phagocytic cells that attempt to kill 
microorganisms. Macrophages secrete growth factors into the wound environment. 
Then fibroblast and endothelial cells express integrins to migrate and secrete growth 
factors, as do epidermal cells. Under normal physiological conditions (upper right 
panel), the wound continues to heal. Migrating epidermis now travels over newly 
formed tissue. In repair settings, proteases are crucial for invasion of the clot and 
ingrowth of the wound. Platelets, macrophages, epidermal and endothelial cells and 
fibroblasts secrete many growth factors. When microbial invasion interrupts wound 
healing (lower right panel), venous failure results in fluid transudation and fibrin cuffing. 
Microorganisms very often produce biofilms that protects colonies of mixed organisms, 
resisting both phagocytic cells and antibiotics (Clark et al., 2007). 
1.2 Clinical epidemiology of trauma-associated fungal wound infections 
 In most cases of trauma-associated fungal infections, fungi are introduced into 
the wound as spores from environmental contamination, which are then able to 
germinate and spread. This is particularly problematic in a range of settings that I will 
now discuss further. 
War 
 It is well known that military wounds are typically different from civilian wounds 
in terms of the mechanism of injury and level of contamination (Evriviades et al., 2011). 
During recent conflicts in Afghanistan or Iraq, many patients had wounds heavily 
contaminated with environmental fungi such as Mucormycetes spp., Fusarium spp., 
Aspergillus spp., Penicillium spp., or Chaetomium spp. (Evriviades et al., 2011). 
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Rodriguez et al. (2014 a, b) have collected data for the Trauma Infectious Disease 
Outcome Study (TIDOS) about US military personnel from the Department of Defense 
(DoD) Trauma Registry and the Department of Veterans Affairs (VA) (Rodriguez et al., 
2014 a, b). They have described that Invasive Fungal Infections (IFIs) associated with 
traumatic injuries tend to be associated with a morbidity and mortality rate as high as 
11-38 %. IFI has also been associated with a higher rate of lower extremity 
amputations (79 % in comparison to 46 % in a control group of patients), and those 
infections were more hypotensive (low blood pressure) and acidotic (increased acidity 
in the blood and other tissues) then a control group. Patients that have developed IFI 
have also receive larger volumes of packed red blood cell (PRBC) transfusion (median 
29 U), compared to the control group (11 U) (Rodriguez et al., 2014 a). Overall, the 
patient group with recurrent wound necrosis were infected mainly with Mucormycetes 
spp. (11 %) and all have been treated with antifungal ((liposomal amphotericin B 
(ampB)) for about 5 days (Rodriguez et al., 2014 b). Tribble & Rodriquez (2014) have 
reviewed US military patients that have been infected with fungal pathogens during the 
Iraq and Afghanistan conflicts ranging over 2001-2011. Their research reveals that 
limb amputations following injuries resulted in 3.6 per 100 combat, with significant 
increase in number of amputations from 3.5 per 100 combat in 2010 to 14 in 2011 
(Tribble & Rodriquez, 2014). Combats who had a traumatic injury usually undergo 
three washouts and/or debridement in the first 72 hours after injury, followed by wound 
assessment and continued debridement within first 12 hours on arrival to USA. 
Similarly to Rodriguez et al. (2014 a, b), Tribble & Rodriquez (2014) links risk factors 
of IFI to substantial blood transfusion which might have an immunosuppressive effect 
and supply of iron, associated with Mucormycetes spp. infections (Tribble & Rodriquez, 
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2014). Among fungal species that caused infections in US military patients suffering 
from traumatic wound injuries, Mucormycetes are the predominant species isolated 
from 35 % of cases (Mucor spp. 62%, Rhizopus spp. 4%, Apophysomyces elegans 
5%, Sakseana vasiformis 14%), then Aspergillus spp., Fusarium spp., Scedosporium 
spp. Blyth et al. (2014) have also presented data showing Candida spp. to be 
associated with wounded military personnel with mortality rate of 7.1 %, however, they 
state no medical evidence that this mortality is due to Candida infection (Blyth et al., 
2014). Mitchell et al., (2014) have reported on mucormycosis infections (infections 
caused by species belonging to order Mucormycetes) from January 2003 to November 
2009, presented in an adult burn center in Huston (United States), and found 2.4 per 
1000 admissions were due to traumatic or burn injury (including patients injured in Iraq 
or Afghanistan during war). While, Warkentien et al. (2012) reported that 83.3 % of 
combat patients had at least 1 fungal species isolated from their wound(s) from June 
2009 to December 2010. More specifically, those fungi isolated were identified as 
Mucormycetes spp., Fusarium spp. and/or Aspergillus spp. Kronen et al. (2017) 
research shows post-traumatic IFI in military personnel caused by Mucormycetes, 
Aspergillus and Fusarium spp., 34%, 31% and 22% respectively. A wide diversity of 
Aspergillus spp. infect such wounds, including: A. terreus 10%, A. flavus 9% and A. 
fumigatus 1%. Other fungal species associated with military wound infections were 
Lichtheimia, Apophysomyces, Aspergillus niger, Bipolaris, Penicillium, Alternaria, 
Scedosporium, Graphium, Candida spp. (Kronen et al., 2017). This research also 
confirms others risk factors associated with IFI wound injuries, such as extensive blood 
transfusion, blast injury, dismounted status and above-knee amputations. McDonald 
et al. (2018) research highlights that many military personnel from the wars in Iraq and 
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Afghanistan remain at significant risk for trauma-related infections for many years 
following injury. 38% of enrolled patients developed new trauma-related infections after 
their initial hospital discharge and 29% of such infections occurred after leaving military 
service (McDonald et al., 2018). All the data summarised above by different research 
groups are similar in terms of morbidity and mortality rate associated with traumatic 
injuries, risk factors and fungal species that are linked with IFI.  
 Weintrob et al. (2015) have investigated epidemiology and clinical classification 
of traumatic wounds of 1133 US combat personnel injured during service in 
Afghanistan (2010-2011), among which 6.8 % had IFI. They research usefully 
describes the classification of IFI, which is often lacking in other reviews. For a proven 
IFI case they describe patients with confirmed angioinvasion of fungal elements on 
histopathology samples, and describe probable IFI as those with fungal elements 
identified from histopathology without angioinvasion (Weintrob et al., 2015).  “Possible 
IFI” were all cases in which mould has grown in tissue, however fungal elements were 
negative in histopathology, and those that had wound tissue with grown mould but 
histopathology was not sent for evaluation were classified as an unclassifiable IFI 
(Weintrob et al., 2015).  Hospitalization in the case of proven/probable cases was 
around 36-71 days, while for the possible/unclassifiable cases that time duration lasted 
for 29-57 days.  22 % of patients with proven/probable cases had amputations in 
comparison to possible/unclassifiable cases, whose amputation rate was 13 % 
(Weintrob et al., 2015).  16 % of IFI patients did not receive any antifungals, and those 
who has received dual antifungal treatment (usually liposomal ampB and voriconazole) 
were proven/probable cases- 59 % versus 44 % in possible/unclassifiable cases. 
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Mortality rate was 9.3 % vs 4.3 % in proven/probable cases vs possible/unclassifiable 
cases respectively (Weintrob et al., 2015).   
 The type of infection and mortality rate of military patients are greatly associated 
with environmental factors, such as temperature and humidity. Tribble et al., (2015) 
have described environmental characteristics, risk factors of injury and risk of 
developing IFI after combat trauma in Afghanistan in 2009-2011. For instance, military 
personnel in southern Afghanistan exhibited an increased risk of developing IFIs 
relative to those from the eastern region (61% vs. 20% respectively). This likely reflects 
the fact that the southern region was much warmer, with higher isothermality (constant 
temperature) and humidity than the eastern region, thus supporting higher levels of 
fungal growth. Similarly, in Iraq, where environmental conditions are comparable to 
southern Afghanistan, there is also a higher frequency of fungal wound contamination 
(Tribble et al., 2015).  
 Traumatic wound infections caused by combat injuries are very common. 
Delayed diagnosis at field hospitals and time needed for patients transport very often 
ends with extensive surgical debridement and/or a high mortality rate. Therefore, there 
is a need for an easy to apply, effective and cheap treatment that can be used at the 
site and time of the injury. 
Environmental and man-made disasters 
 During environmental disasters such as tsunami or earthquakes, survivors often 
receive wounds with high levels of environmental contamination. Amid wounded 
survivors of tsunami disasters, around two-third of patients’ wounds become infected 
in the first 72 hours (Wuthisuthimethawee et al., 2015). Those wounds tend to be 
contaminated with environmental pathogens and foreign matter, the crushed and dead 
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tissue providing a medium for bacterial and fungal growth. Following the 2004 tsunami 
disaster in Southeast Asia, patient’s wounds were contaminated with both sea and 
fresh water, soil, sewage, and various foreign matter containing environmental 
pathogens that were very problematic to treat (Maegele et al., 2006). Factors such as 
delayed wound cleaning, patient transport to hospital and primary wound closure are 
very often a reason for subsequent deep surgical debridement and an associated high 
mortality rate. Traumatic injuries are also very common in vehicle accidents or 
agricultural injuries (Vitrat-Hincky et al., 2009). Near-drowning accidents are also case 
of invasive fungal infections, especially of S. apiospermum (He, X.H. et al. 2015). 
Similarly to military patients, civilian traumatic injuries are most commonly infected with 
fungal pathogens such as Mucormycetes, Scedosporium, Aspergillus and Fusarium 
species (Kronen et al., 2017). Post-traumatic filamentous fungal infections are 
particularly associated with traffic (41 %) and agricultural (25 %) accidents as well as 
natural disasters (12 %) (Kronen et al., 2017). Overall, civilians often receive a delayed 
diagnosis compared to military personnel, perhaps due to postponement in sampling. 
Diagnosis following a tornado in Joplin (Missouri) ranged from 10 to 19 days (time from 
sample collection to diagnosis) (Kronen et al., 2017). Risk factors for IFI in civilian 
patients affected with traumatic injuries are wound contamination by soil, plant matter 
and gravel. Wearing synthetic fabric at the time of injury might also support IFI due to 
the moisture and warmth of the skin in comparison with cotton clothes (Kronen et al., 
2017). Overall mortality rate for trauma-associated fungal infected civilian patients is 
25-41 %, and most occur within first 2 weeks of hospitalization (Kronen et al., 2017). 
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1.3 Introduction to trauma associated fungal pathogens 
Mucormycetes  
 Life cycle. Mucormycetes spp. belongs to the phylum Glomeromycota and 
subphylum Mucormycotina (Müller et al., 2018). Within the phyla, the order 
Mucormycetes contains the genera Mucor, Rhizomucor, Rhizopus and Lichtheimia 
(Kauffman, 2004), which, together, cause most cases of human mucormycosis. These 
fungal species reproduce both sexually and asexually. In the asexual reproduction, on 
the apex of sporangiophorex, a sporangium is present (Mendoza et al., 2014). 
Sporangia contain sporangiophores which disperse and then germinate to produce a 
mycelial complex in favourable environmental conditions. During their sexual 
development, two mating types of hyphae (+) and (-), sense each other, followed by 
gamete fusion that forms zygospores (Mendoza et al., 2014). These zygospores have 
the ability to germinate and form a sporangium (at the apex) containing sexual 
meiospores (Mendoza et al., 2014).  Xu et al. (2017) have shown that sexual 
reproduction coupled with meiosis and recombination plays a role in virulence and 
pathogenicity. It is well known that during fungal sexual reproduction, different mating 
types are required to form gametes/sexual fusion (Xu et al., 2017). This process is 
controlled by a genomic region known as the mating type locus (MAT). In 
Mucormycetes spp., mating is regulated by divergent alleles of a single gene 
(SexM/SexP). This gene consist of high mobility group (HMG) transcription factor gene 
between genes encoding phosphate transporter homologue (TPT) and RNA helicase 
(Xu et al., 2017). 
 Infection. The past two decades has shown an increase in patients with 
mucormycosis due to many underlying diseases (Pfaller and Diekema, 2004). Such an 
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increase in mucormycosis is associated with a high morbidity and mortality rate and is 
the result of an increased patient population at risk from the development of serious 
fungal infections (Pfaller and Diekema, 2004). The mortality rate associated with 
patients suffering from mucormycosis can be as high as 40-70 % (Müller et al., 2018). 
For example, in France, mucormycosis represents 1.5 % of 35876 cases with invasive 
fungal infections with an increase of 7.3 % per year (2006) (Lortholary, Fernández-
Ruiz & Perfect, 2016).  Haematological malignancy patients as well as the healthcare 
associated outbreaks represented 50-70 % of mucormycosis cases in 2016, while 
diabetic patients 20 % of mucormycosis in Europe and USA (Lortholary, Fernández-
Ruiz & Perfect, 2016).  At risk patients are those who have received organ or stem cell 
transplant, patients with diabetes mellitus, malignancy or neutropenia and those who 
receive deferoxamine therapy (therapy used to remove excess of iron from the body 
e.g. to treat hemochrombatosis) or injection drug users (Roden et al., 2005). Rhizopus 
arrhizus is the most common species isolated from clinical samples (Müller et al., 
2018). Though, there are also cases of mucormycosis in patients that are not 
immunocompromised (Venkatesh et al., 2018; Dogra, Bhutani and Gupta, 2018). As 
Mucormycetes are pervasive environmental fungi found in soil and decayed wood, 
injuries that introduce such environmental material into the wound are at a higher risk 
of developing necrotizing cutaneous mucormycosis. Mucormycetes spp., are the third 
emerging group of fungal pathogens related to post-trauma infection, representing 20 
% of cases (Lortholary, Fernández-Ruiz & Perfect, 2016). Epidemiological studies 
show that varying underlying conditions are subjected to different localisations of 
mucormycosis, for example patients with organ transplant are in risk of getting infection 
of that organ; victims of traumatic injury of the infection of the side of wound; or 
  11 
agricultural workers, nasal or brain infection followed by spore inhalation (Tacke et al., 
2014).  
 Virulence traits. Morace & Borghi (2012) have reviewed virulence and 
pathogenesis caused by Mucormycetes spp. and describe their iron association, and 
their ability to acquire iron from host with enhanced growth and hyphal development of 
Mucormycetes spp. in vitro and their increased pathogenicity in vivo. A novel host 
receptor GPR78 (the glucose-regulated protein 78), was shown to be required for 
pathogenesis of Rhizopus oryzae in diabetic mice (Liu, M. et al., 2010). They presented 
that high glucose and iron presence, regulate increase expression of GPR78 causing 
endothelial cells damage, however, the fungal ligand is unknown (Liu, M. et al., 2010).   
 Xu et al. (2017) research on 17 clinical isolates of Mucor irregularis from patients 
in China, showed that (+) mating type isolates caused greater lesion and more damage 
than the (-) mating type isolates. They have concluded from that research that mating 
types might have a correlation with the severity of inflammation, although it may not be 
directly linked to a virulence factor, the M. irregularis had a different level of immune 
response (especially Th-1 and Th17 pathway) to different mating type (Xu et al., 2017). 
They have also compared their results to others, stating that (+) mating type had an 
increased pathogenicity in Mucor piriformis when used as inoculum in plant causing 
larger lesion then (-) mating type of this isolate (Michailides & Spotts., 1986); or (+) 
mating type of Mucor amphibiorum is able to cause severe infection in toads in 
comparison to (-) type (produced spherules more rapidly leading to better 
dissemination) (Stewart & Munday., 2005).  In contrast (-) mating types of Mucor 
circinelloides F. lusitanicus (Mcl) were more virulent in the wax moth host in 
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comparison to (+) mating types, however, the loss of virulence in (-) mating types was 
correlated to the sporangiospore size not necessarily to the MAT locus (Li et al., 2011). 
Scedosporium, Lomentospora 
 Life cycle. Scedosporium and Lomentospora spp. are pervasive environmental 
fungi, generally found in soil, polluted water, sewage, as well as indoor air (Cortez et 
al., 2008).  Similarly to Mucormycetes spp., they reproduce sexually and asexually. 
Telomorph (sexual reproductive stage) of Scedosporium/Lomentospora spp. strains 
spontaneously produce fruit bodies called ascigerous (Guarro et al., 2006). P. boydii 
(also called S. apiospermum), for example, produce cleistothecia (closed fruit bodies) 
which are yellow-brown to black coloured with spherical shape and size of 140-200 m 
in diameter. When this are crushed, they release thin-walled, spherical, evanescent 
asci, which quickly dissolve to release 8 lemon-shape, golden-brown in colour 
ascospores, 4-5 x 5-7 m in size (Guarro et al., 2006). The anamorph (asexual 
reproductive stage) is almost invariably present in Scedosporium/Lomentospora spp. 
It is composed of hyaline cylindrical conidiogenous cells growing of from 
undifferentiated hyphae. Those cells produce obovoidal, brown and sticky conidia, with 
size of 4-9 x 6-10 m, from a short extensions (Guarro et al., 2006). 
 Infection. Within the genus Scedosporium there are two medically important 
species, Scedosporium prolificans (now renamed to Lomentospora prolificans) 
(Lackner et al., 2014) and Scedosporium apiospermum. S. apiospermum and S. boydii 
(previously P. boydii) have a worldwide distribution, while L. prolificans infrequently 
encountered in an environmental samples and used to appear more commonly in the 
climates of Australia and Spain, but more recently has been recognized in other 
European countries, USA and Korea (Ramirez-Garcia al., 2018).   Scedosporium spp. 
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account for 25% of non- Aspergillus fungal infections (Campa-Thompson et al., 2014). 
The first reported case of human disease caused by Scedosporium was described in 
1889 (otitis), and the infectious species was P. boydii (Cortez et al., 2008). Human 
infections caused by Scedosporium, Lomentospora spp. were initially primarily 
subcutaneous infections caused by trauma, which typically affected the feet of 
barefooted, native workers in India and so at that time the disease was called “Madura 
foot” after the region of Madura (India) where it was first identified (Cortez et al., 2008). 
However, in the early 1980s similar fungal infections started to occur in 
immunocompromised patients and today cases that disseminate to surrounding 
tissues or organs are not uncommon (Campa-Thompson et al., 2014; Torres-Sánchez 
et al., 2018). The fungus can cause airway abnormalities, including allergic 
bronchopulmonary reaction, by colonizing the respiratory tract, or disseminated 
diseases within skin and soft tissues such as ligaments or tendons. Other diseases 
caused by Scedosporium, Lomentospora spp. include: keratitis, otomycosis, septic 
arthritis, pneumonia, meningitis etc. (Cortez et al., 2008). Interestingly, Scedosporium, 
Lomentospora spp. infection is commonly found in near-drowning patients (i.e. those 
who have had extensive immersion underwater) especially if brain abscess or 
pneumonia has been diagnosed. There are no documented cases of Scedosporium, 
Lomentospora being transmitted from person to person (Campa-Thompson et al., 
2014). Infections caused by Scedosporium, Lomentospora account for around 3% of 
all infections caused by fungi in post-transplant patients, with a mortality rate of 70% 
(Acharya et al., 2006). Ramirez-Garcia al. (2018) recently have recently summarized 
risk factors for Scedosporium/Lomentospora spp. infection such as: solid organ 
transplant, where Scedosporium/Lomentospora spp., infections are two-thirds of all 
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infections caused by those species; hematopoietic stem cell transplant; cancer and 
other immunodeficiencies (Ramirez-Garcia al., 2018). Central Nervous System (CNS) 
involvement in scedosporiosis (infection caused by species belonging to 
Scedosporium and Lomentospora) has been described including cases of solitary or 
multiple brain abscesses, meningitis and ventriculitis (Acharya et al., 2006). 
Scedosporiosis has also been stated to cause ostyomelitis (infection in a bone), 
endocarditis (inflammation of heart’s inner lining), arthritis (joins disorder) and cystic 
bronchiectasis (bronchi or airways infection) in immunocompetent patients. Airway 
colonization by Scedosporium spp. in patients with cystic fibrosis starts during 
adolescence and become chronic in up to 54 % cases (Ramirez-Garcia al., 2018). 
German cystic fibrosis centre study presented by Schwarz et al. (2017), showed 
Scedosporium-Lomentospora infections to be 4 %, in France 8.6 %, Australia 17.4-25 
%. They also presented that patients with those infection significantly reduced co-
colonisation with H. influenza and with Candida spp., and increased co-colonisation 
with the mucoid phenotype of P. aeruginosa (Schwarz et al., 2017). There have also 
been cases of lung cancer patients with scedosporiosis and co-infection of Aspergillus 
fumigatus in cystic fibrosis patients (Hirschi et al., 2012). Bronchial infection by those 
species can lead to chronic inflammation or life-threating invasive disease in case of 
lung transplant or hematological malignancy (Ramirez-Garcia al., 2018). 
Scedosporium but not Lomentospora spp. has also been linked to allergic 
bronchopulmonary mycoses that are about 3 % of all cases (Ramirez-Garcia al., 2018). 
 Virulence traits. Mello et al. (2018 a) have investigated the surface properties, 
adhesion and biofilm formation by different species of Scedosporium and 
Lomentospora. They showed that cell surface hybrophobicity (CSH) in S. 
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apiospermum, S. minutisporum, S. aurantiacum and L. prolificans influences adhesion 
and biofilm formation by those species. Zeta potential is the parameter that determines 
the electronic mobility of charged particle in a liquid media and represents the 
electronic double layer around the cell (Mello et al., 2018 a). This can be used to 
measure cell adhesion to the surfaces. Mello et al. (2018 a) have also measured 
electric charges of above mentioned species in context of melanin, and found that L. 
prolificans and S. minutisporum with higher electronegative charge were producing 
more melanin then S. apiospermum and S. aurantiacum that are less electronegative 
ones. They have also compared Scedosporium/Lomentospora ability to adhere to 
poly-L-lysine coated glass (positively charged) and showed enhanced adhesion in 
comparison to non-coated glass (Mello et al., 2018a). These strains have also 
produced distinct amount of adhesive mannose-rich molecules. Biomass and 
metabolic activity of Scedosporium/Lomentospora strains have reached the maximum 
after 72 hours, while production of extracellular matrix has been reached at 24 hours 
(Mello et al., 2018 a). Lastly, Mello et al. (2018 a) have checked whether Scedosporium 
and Lomentospora spp. can form biofilm on different medical devices, such as a 
nasogastric catheter made from a polyvinyl chloride, a late bladder catheter of 
siliconized latex, and a polyurethane nasoenteric catheter. All fungal species formed 
biofilms on all devices with S. aurantiacum and S. minutisporum formed thicker biofilms 
than S. apiospermum and L. prolificans (Mello et al., 2018 a). 
  Ramirez-Garcia al. (2018) review few virulence factors that has been published 
so far, such as: ability of conidiation (ability to produce spores) in host tissue by L. 
prolificans, that helps dissemination (Ortoneda et al.,2002); peptidorhamnomannan 
(PRM) that is expressed in both, conidial and hyphal cell wall, has been shown to be 
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related with adhesion and endocytosis by epithelial cells and macrophages, therefore, 
might facilitate virulence and dissemination (Pinto, M.R. et al., 2004; Barreto-Bergter, 
E. et al., 2008; Xisto, M.I. et al., 2016); -glucan, found in P. boydii surface, has been 
shown to be essential conidial phagocytosis and induce cytokine secretion by immune 
cells involving TLR2, CD14 and MyD88 (Bittencourt, V.C.B. et al., 2006). More 
virulence traits summarized in the Ramirez-Garcia al. (2018) review are: 
glucosylceramides (GlcCer) (neutral glycosphingolipids) expressed by S. 
apiospermum are associated with growth, differentiation and infectivity of fungal cells 
(da Silva, A.F. et al., 2004; Pinto, M.R. et al., 2002); enzymes, such as Cu/Zn cytosolic 
superoxidase dismutase and monofunctional catalase from P. boydii are important for 
evasion of immune system (Lima, O.C. et al., 2007); melanin has also been shown to 
be involved in virulence by protecting fungus from UV, oxidative killing and H2O2, but 
not ampB (Al-Laaeiby, A. et al., 2016).  
 Mello, T.P. et al. (2018 b) review also points out at few virulence traits of 
Scedosporium/Lomentospora spp., such as the fact that Scedosporium/Lomentospora 
spp. germination is influenced by at 37 C and CO2 (5 %); or that the MIC value to 
different antifungals is always higher for conidia then a germinated conidia, supporting 
their survival and growth within host tissue (Mello, T.P. et al., 2018 b). 
Fusarium 
 Life cycle. Similarly to the above mentioned fungal pathogens, Fusarium spp. 
also reproduce both, sexually and asexually, with haploid mycelial structures that are 
formed in both developmental stages (Dweba, C.C et al., 2017). Mycelial structures 
produce three types of mitotic spores during their asexual life cycle. These are: 
conidiophores that produce microcondia; sporodochium that produce macrocondia; 
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and hyphae within which clamydospres are being produced (Dweba, C.C et al., 2017). 
During sexual life cycle, fungus grows as a haploid colony of hyphae and diploid stages 
preceding meiosis and the production of haploid, sexually produced spores called 
ascospores (Ma, L.J. et al., 2013). The flask shaped structure, called perithecium, 
contains a sac (ascus) that produce ascospores. Homothallic species are able to self-
fertilize resulting in production of clonal ascospore progeny (apomixis), while 
heterothallic species are self-sterile (Ma, L.J. et al., 2013). Both sexual orientations 
result in airborne spores (Dweba, C.C et al., 2017). 
 Infection. Genus Fusarium consist of 70 species, with 12 causing human 
infections (Lortholary, Fernández-Ruiz, & Perfect., 2016). Fusarium spp. causes a 
distinctive range of infections, which include locally invasive, disseminated infections 
or superficial (onychomycosis, keratitis) infections (Nucci and Anaissie, 2007). Most 
superficial infections such as onychomycosis or fungal keratitis in immunocompetent 
individuals, or disseminated infections in immunocompromised patients with mortality 
rate up to 70 % in those cases (Lortholary, Fernández-Ruiz, & Perfect., 2016).  
Fusarium species can also cause allergic diseases in immunocompetent (sinusitis) and 
immunocompromised (mycotoxicosis) individuals (Nucci and Anaissie, 2007).  
 Other infections in immunocompetent patients caused by Fusarium spp. are 
osteomyelitis (bone infection), pneumonia (lung infection), fungemia (blood infection 
by fungi or yeast), septic arthritis (joint inflammation followed by infection) or sinusitis 
(sinus infection) (Nucci and Anaissie, 2007). There are many species of Fusarium that 
have been identified (more than 50) but only a few cause diseases in humans. These 
are primarily F. solani, which is the most common (~50 % of cases), and F. oxysporum 
(~20 % of cases) (Nucci and Anaissie, 2007; Lortholary, Fernández-Ruiz, & Perfect., 
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2016). F. falciforme (one of the species belonging to F. solani complex) is an emerging 
and one of the most virulent Fusarium spp. associated with fusariosis and keratitis (Al-
Hatmi et al., 2016).  More than 300 cases of Fusarium keratitis were associated with 
contact lens cleaning solution causing outbreak in 2005-2007, where F. solani was 
predominant (Al-Hatmi et al., 2016). Individuals who are receiving corticosteroid 
treatment or are neutropenic are particularly at risk of infections. As with the 
Mucormycetes and Scedosporium, Fusarium causes localized infections in 
immunocompetent people as well as disseminated infections in immunocompromised 
hosts. Nucci and Anaissie, (2002) have described fusarial skin infections in both 
immunocompetent and immunocompromised patients based on MEDLINE report 
cases research between January 1966 and October 2001. Comparing to other fungi 
like Candida or Aspergillus species, infections caused by Fusarium represent >50 % 
of skin infections, while no other species accounts for more than 10 % (Nucci and 
Anaissie, 2002).  Epidemiologically, Fusarium has been recovered from hospital air, 
general water systems and other environments (Nucci and Anaissie, 2007).   
The number of invasive fungal infections has increased over the last two decades in 
severely ill, hospitalised patients, in which fusariosis (infection caused by Fusarium 
spp.) is a main skin or superficial infection (Scheel et al., 2013).  
 Virulence traits. Fusarium spp. have ability to produce mycotoxins, including 
trichothecenes, which are known to suppress humoral and cellular immunity and ability 
to damage host tissue (Jain et al., 2011). The ability to adhere to prosthetic material 
and production of proteases and collagenases is another virulent trait proposed by Jain 
et al. (2011). Factors important for Fusarium infections differ between plant and animal 
hosts.  For instance, Nucci & Anaissie. (2007) showed that a mitogen-activated protein 
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kinase was virulent in tomato plant but not in mice in terms of F. oxysporum infection, 
whereas a pH response transcription factor was important for infection in mice but not 
in plants (Nucci & Anaissie., 2007). Fusarium spp. sporulates in vivo, facilitating 
hematogenous dissemination, leading to fungemia that occurs in 70 % cases in 
hematopoietic transplant recipients (Kadri et al., 2015).   
1.4 Current antifungal treatments 
 As mentioned previously, the high morbidity and mortality rate due to fungal 
infections is very often due to a delayed diagnosis, misdiagnosis or underlying disease. 
But limited antifungal availability, high toxicity and species-specific antifungal 
resistance are also major problems. Below I will describe types of current antifungals 
and their mechanism of action. 
 Polyenes 
 Drugs such as amphotericin B or nystatin are polyenes and therefore target 
ergosterol, a sterol responsible for membrane fluidity and permeability in fungi 
(Scorzoni et al., 2017). Their mechanism of action is via binding ergosterol, disturbing 
membrane by forming a pore complex that is followed by leakage of important ions 
and cytoplasmic contents. Ergosterol of fungi has cylindrical three-dimensional 
structure, while cholesterol, sterol of mammalian membrane, sigmoid shape (Odds et 
al., 2003). Conformational difference between those two might explain better binding 
of ampB to ergosterol over cholesterol, but also be a reason for high toxicity of ampB 
to mammalian cells (Odds et al., 2003). However, the mechanism of action of 
amphotericin B is fairly controversial. Some researchers showed that disturbing the 
fungal membrane might not be necessarily linked to cell death. One alternative 
mechanism could be that amphotericin B influences auto-oxidation and formation of 
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free-radicals that causes cell death (Lamy-Freund et al., 1985). As also described by 
Scorzoni et al., 2017, who showed that polyenes are involved in a cascade of oxidation 
reactions with lipoproteins.   
 Amphotericin B is a natural product of Sterptomyces nodus (Lestner et al., 2013). 
 
 
Figure 1.2 Chemical structure of polyene. Figure adapted from (Odds et al., 2003). 
 Azole 
 Another group of antifungals that target ergosterol are the azoles. Ergosterol 
depletion and replacement with usual sterols leads to disruption of membrane 
permeability and fluidity (Odds et al., 2003). Molecular target of azole is cytochrome 
P450 (Erg11 in yeast or Cyp51A in moulds), which catalyses the oxidative removal of 
the 14α-methyl group from lanosterol in fungi (Odds et al., 2003; Cowen et al., 2014). 
Antifungal azoles bind to the ferric iron moiety (of the heme-binding site) located on 
the active site of this protein and blocks the enzyme’s natural substrate lanosterol, 
disturbing the biosynthesis pathway (Cowen et al., 2014). P450, conformation of active 
site, differ between fungal species. Therefore, interaction between P450 and azole 
molecule might be different, and the inhibitory effect of azole within fungal species 
(Odds et al., 2003). To groups of azoles belong in between: imidazole (ketoconazole), 
triazoles (fluconazole, posaconazole, voriconazole, isavuconazole) and thiazoles 
(abafungin).  
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Figure 1.3 Chemical structure of azoles. Figure adapted from (Odds et al., 2003). 
 Echinocandin 
 Echinocandins are a class of drugs that includes antifungals such as 
caspofungin, micafungin and anidulafungin.  Echinocandins target the cell wall, in 
particular proteins responsible for synthesis of β-1,3 glucans. This happens by blocking 
the enzyme glucan synthase, resulting in decreasing incorporation of glucose 
monomers between β-1,3 and β-1,6. This results in weakening the cell wall and fungal 
death (Scorzoni et al., 2017). As the cell wall composition varies between different 
fungal species, the echinocadin is not antifungal active against all fungal pathogens 
(Eschenauer et al., 2007). 
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Figure 1.4 Chemical structure of echinocandins. Figure adapted from (Odds et al., 
2003). 
 Alternative drugs under investigation 
 There are also alternative drugs being tested/proposed against filamentous 
fungi such as orotomides against Aspergillus or Lomentospora spp. (Hope et al., 
2017); sphingolipids (Rollin-Pinheiro et al., 2016); N- Chlorotaurine against 
Scedosporium, Lomentospora spp. (Lackner et al., 2015) or proposing cytochrome 
P450 as a new drug target (Jawallapersand et al., 2014). Current treatment also 
includes hyperbaric oxygen and granulocyte colony stimulating factor (Rogers, 2008; 
Goldman et al., 2016). Galvez et al. (2017) isavuconazium sulfate as a treatment for 
burn infection of patients infected with mucormycosis.  
1.4.1 Antifungal treatments for mucormycosis, scedosporiosis and fusariosis.  
 Mucormycosis. Effective treatment of mucormycosis requires an early 
diagnosis as well as prompt initiation of therapy. Treatment for mucormycosis include 
polyenes, except for Cunninghamella spp. and only two triazoles: posaconazole and 
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isavuconazole (but MIC value range is large for the second one) (Lortholary, 
Fernández-Ruiz & Perfect, 2016). Recommendation of antifungals used for treatment 
of mucormycosis include amphotericin B (ampB) and posaconazole (PSC). AmpB, has 
been a mainstay treatment for several decades despite its association with 
considerable kidney toxicity (Almyroudis et al., 2007). More recent lipid formulations of 
ampB (Ambiosome) are much less nephrotoxic and can be safely administered at 
higher doses for a longer period of time (Spellberg et al., 2009). PSC appears to be 
well tolerated, and is recommended to be used for treatment if there is ampB 
intolerance or in patients who did not respond to previous antifungal therapy (Enoch et 
al., 2011, Kim and Williams, 2014). A number of research groups have been testing 
different antifungals and their MICs against various Mucormycetes species and 
isolates and confirmed ampB as a first choice of treatment, followed by posaconazole 
(Spellberg et al., 2009; Rogers, 2008; Cornely et al., 2009; Enoch et al., 2011; 
Greenberg et al., 2006; Kim and Williams, 2014). Rogers (2008) suggested that PSC 
is a good oral treatment for mucormycosis and suggested that comparison of 
posaconazole and lipid amphotericin B should be tested as a primary treatment to find 
out which may have greater efficiency, although this has not yet been undertaken. 
Fluconazole, voriconazole, caspofungin and echinocandin showed poor or no activity 
against Mucormycetes spp. (Almyroudis et al., 2007). In addition, surgical debridement 
is an effective way to treat patients suffering from mucormycosis, although in practice 
there are difficulties in achieving this as important structures are often adjacent to 
necrotic tissues: particularly in rhino-orbital, sinu-nasal and especially, cerebral 
involvement (Cornely, Vehreschild, and Rüping, 2009). Therefore, there is a need for 
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improved antifungal treatment to reduce the need for such surgical (and often 
debilitating) treatments.  
 Scedosporiosis. As described above, scedosporiosis is common in both 
immunocompetent and immunocompromised patients; moreover, many isolates are 
highly resistant to antifungals, especially L. prolificans, which is multidrug resistant 
(Pellon et al., 2018 b).  
Scedosporium, Lomentospora species have varying MIC (Minimum Inhibition 
Concentration)/MEC (Minimum Effective Concentration) distributions; therefore 
predicting susceptibility to any antifungal in a particular strain is problematic (Lackner 
et al., 2012). Lackner et al. (2012) have shown that L. prolificans is resistant to 
amphotericin B, intraconazole, posaconazole and isavuconazole (Lackner et al., 2012 
and Zeng et al., 2004) and that these drugs show very limited efficacy towards S. 
apiospermum. Voriconazole has been shown to have an antifungal activity against 
Scedosporium spp. (Tucker et al., 2015). These results have been confirmed by Mello 
et al. (2016) showing only voriconazole being effective against S. apiospermum and L. 
prolificans, in comparison to ampB, caspofungin, fluconazole and intraconazole, all 
being non-effective against those strains. Similar observation were published by Gil-
Lamaignere et al., 2002; Masukane et al., 2017; Wang et al., 2015. Posaconazole has 
also shown to have a good activity against Scedosporium spp. (Sabatelli et al., 2006). 
However, Lackner et al. (2012) have observed species-specific cross-resistance 
between Scedosporium spp. to different azoles. Recently Ramirez-Garcia al. (2018) in 
their review summarised that Scedosporium spp. are resistant to 5-flucytosine (drug 
targeting synthesis of fungal RNA and DNA), ampB, first generation triazole drugs, 
fluconazole and itraconazole. They are less susceptible to echinocandins, specifically 
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to caspofungin and anidulafungin, and have also shown resistance to the most recent 
triazole drug such as isavuconazole (Ramirez-Garcia al., 2018). For 
Scedosporium/Lomentospora spp. infections, European guidelines recommend 
voriconazole as a first line treatment and surgical debridement (Ramirez-Garcia al., 
2018). 
 Therefore, investigating innate immune interaction with these pathogens is very 
important to understand difficulty with current antifungal resistance and development 
of new drugs. 
 Fusariosis. Invasive fusariosis contributes to 1/4 of cases of invasive fungal 
infections (Lortholary, Fernández-Ruiz, & Perfect., 2016). The current antifungal 
therapy of choice for fusariosis is amphotericin B, or/and voriconazole and 
posaconazole (Tortorano et al., 2008). However, these treatments show poor in-vitro 
activity (Pujol et al. 1997), and fusariosis involving haematogenous dissemination 
almost always results in mortality (O'Donnell et al., 2008). Therefore, clinical treatment 
of fusariosis essentially depends on the immune status of the host and the fungal route 
of entry (Tortorano et al., 2008). From a single cancer center with 44 cases of proven 
invasive fusariosis, 1/3 of patients had a breakthrough infection, despite the fact that 
most of them have been receiving prophylaxis treatment with voriconazole or 
posaconazole (Lortholary, Fernández-Ruiz, & Perfect., 2016).  Al-Hatmi et al. (2016) 
investigated drug susceptibility among different strains of Fusarium and found them to 
be resistant to almost all antifungals (azoles and polyenes) being currently in use. 
While, Tortorano et al. (2008) showed ampB being the most effective against Fusarium 
spp., the distribution and pattern along different species and susceptibility to drugs is 
very variable.  
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Again, the host innate immune system plays a huge role in fighting against fungal 
infections. Schäfer et al. (2014) demonstrated that murine macrophages migrate 
towards and internalize germinated microconidia. Similarly, other research group has 
also shown importance of innate immune cells in fighting Fusarium spp. (Sun et al., 
2010; Tarabishy et al., 2008; Jin et al., 2007; Karthikeyan et al., 2011). 
1.4.2 Antifungal resistance 
 1,350,000 deaths are caused by fungal infections annually, with more than 300 
million people suffering from it (Brown et al., 2012). Antifungal resistance is a rising 
problem in clinical cases and those might be due to few factors described below.  
 Widespread of antifungal agents in agriculture is one of cause of rising 
antifungal resistance; medical and surgical devices, such as catheters and artificial 
heart valves are known to be contributing to biofilm formation, therefore accompanying 
drug resistance (Cowen et al., 2014). Microbial resistance can be primary or 
secondary. Primary resistance occurs when the pathogen is inherently less susceptible 
to a given antifungal drug, while secondary resistance involves a pathogen acquiring 
resistance during antifungal treatment. Therefore, drug penetration to the site of 
infection may also contribute to antifungal resistance (subclinical reservoirs of fungal 
spores/cell that has not been reached/killed by drug are seeding new infection) (Cowen 
et al., 2014). Host immune status is one of most important factor in antifungal 
resistance as a fungistatic drug must work synergistically to control and clear the fungal 
abundance (Cowen et al., 2014).   
Antifungal resistance mechanism is a broad and complex subject, therefore only a few 
mechanisms will be pointed out in this research thesis basing on the review of Cowen 
et al. (2014). 
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 Azole resistance. Amino acid substitution in the drug target are common azole 
resistance mechanism known in fungal species; ERG11 mutations; efflux pumps, 
which recognize diverse chemicals enabling multidrug resistance; ABC proteins (ATP-
dependent transporters such as CgCdr1, CgCdr2, CgSnq2, Afr1); MFS transporters 
(use the electrochemical proton-motive force to power drug efflux); multiple genomic 
alterations (e.g. loss of heterozygosity); mitochondrial dysfunction; biofilms formation 
and cellular stress response (Hsp90) (Cowen et al., 2014; Odds, Brown, & Gow, 2003; 
Robbins, Leach& Cowen, 2012). 
 Echinocandin resistance. This is commonly associated with amino acid 
substitutions in the Fks subunit of glucan synthase; multidrug transporters; biofilm 
growth; stress adaptation responses and fungal stress tolerance (Hsp90, cell wall 
integrity, protein kinase C, Ca2b/calcineurin/Crz1, and high osmolarity glycerol 
cascades contributes to fungal cells survival following echinocandins treatment) and 
increased chitin synthesis (Cowen et al., 2014). 
 Antifungal resistance in Mucormycetes spp. Mucormycetes are resistant to 
triazoles (Gamaletsou, Walsh & Sipsas, 2018). Caramalho et al. (2017) research have 
shown that Mucormycetes spp. show in vitro resistance to the short-tailed azoles TDM 
(therapeutic drug monitoring) (median MIC >16.00 mg/l) and fluconazole (median MIC 
>64.00 mg/L) and variable susceptibility of those fungal species to long-tailed triazole 
posaconazole (MIC 2.00-8.00 mg/L) and the polyene amphotericin B (MIC 0.50-2.00 
mg/L). Amino acid substitution in Mucormycetes spp. LDM (inhibition of lanosterol 14- 
demethylase) that differently affect the binding of short- and long-tailed may be the 
reason for this phenomenon (Caramalho et al., 2017). Similarly to those, Sagatova et 
al. (2016) have shown that Mucormycetes spp. are resistant to voriconazole as they 
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had substitution of Y129F, V and A of the active site of LDM F5, but not LDM F1. 
However, both LDM isoforms are expressed while exposed to voriconazole, they 
proposed those substitutions as a selective resistance mechanism of short-tailed 
azoles (Sagatova et al., 2016). Müller et al. (2018) research of azole activity in 
Mucormycetes spp. have shown that their sterol composition has been alerted 
following azole treatment but did not lead to reduction of total sterol content. One of 
the substrates of the azoles target, enzyme C14-demythelase (eburicol), and its high 
amount might cause less accumulation of non-physiological intermediates due to azole 
treatment and its lower activity in comparison to other moulds (Müller et al., 2018).  
 Antifungal resistance in Fusarium spp. Fusarium spp. are intrinsically 
resistant to azole antifungals (Al-Hatmi, Meis and Sybren de Hoog., 2016). Azoles are 
cheap drugs that have a broad-spectrum activity and stability and are widely used in 
agriculture. Five azoles, such as propiconazole, bromuconazole, epoxiconazole, 
difenoconazole and tebuconazole are used for crop protection, however; they have 
been shown to be associated with function of CYP51 (gene encoding sterol 14-
demethylase) and its role in antifungal resistance (Al-Hatmi, Meis & Sybren de Hoog., 
2016). Mutations of Fks1 gene might also contribute to the echinocandin resistance in 
Fusarium spp. (Katiyar & Edlind., 2009). Katiyar & Edlind. (2009) showed that spot 1 
substitution P647A and F639Y in Fks1 contributes to antifungal resistance in F. solani. 
Berthiller et al. (2013) have shown that efflux mechanism is also involved in antifungal 
resistance in Fusarium spp. The resistance mechanism is involved in effective efflux 
apparatus that is able to remove xenobiotics from its cells, which may reduce azole 
sensitivity (Berthiller et al., 2013).   
  29 
 Antifungal resistance in Scedosporium/Lomentospora spp. Antifungal 
resistance in Scedosporium/Lomentospora spp. is poorly understood to date. This 
might be due to the fact that, for example the L. prolificans, genome is not publicly 
available, so it limits any attempts of comparing the sequence to find homologues or 
differences with other, better studied, fungal species. Also, lack of genomic information 
restrict research from performing genetic-engineering experiments that would help to 
investigate antifungal resistant mechanism (Pellon et al., 2018 b). The few 
investigations to date are described below. 
 Research on Scedosporium and L. prolificans spp. have shown that mutations 
in Fks1 gene, which is known from encoding catalytic subunit of the -1,3-glucan 
synthase, is the factor for antifungal resistance for echinocandins (Ramirez-Garcia et 
al., 2018). Pellon et al. (2018 a, b) research propose molecular mechanisms that is 
related to antifungal resistance, and these are mutations on specific genes, such as 
Fks or Erg11/Cyp51 as well as cellular and molecular changes developed by L. 
prolificans followed exposure to voriconazole, which developed resistance to this drug 
(Pellon et al., 2018 a, b).  Johnson, Katiyar & Edlind (2011) have investigated acquired 
resistance or reduced echinocandin susceptibility (RES) association with two “hot spot” 
regions of Fks1 and Fks2 ( -1,3-glucan synthase). They have presented an evidence 
for W695F substitutions within hot spot 3 of both, S. apiospermum and L. prolificans, 
however, this single mutation did not fully accounted for RES profile in Scedosporium 
spp. suggesting that substitutions elsewhere within Fks1 together with other factors 
might play a role in resistance (Johnson, Katiyar & Edlind., 2011). Biofilm formation 
ability by Scedosporium and Lomentospora spp. reported by Mello et al. (2016) might 
also contribute to antifungal resistance. Ramirez-Garcia et al. (2018) in their overview 
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of Scedosporium/Lomentospora spp. mention Japanese company, Eisai Co., who has 
discovered E1210 (first-in-class antifungal drug) that has an activity against fungal 
infections such as candidiasis, fusariosis and aspergillosis. Such a drug targets the 
inositol acylation step in the biosynthesis pathway of the glycosyl phosphatidyl inositol 
(GPI) anchor (Ramirez-Garcia et al., 2018). The mechanism of action of E1210 is to 
block the inositol acetylation step to cause defect in fungal cell wall biosynthesis, 
hyphal growth and ability of fungal cells adherence to biological substrates. This 
promising drug however, has been shown to have a 10-fold lower MIC against S. 
apiospermum, S. aurantiacum and L. prolificans than to voriconazole, which suggests 
those species developed a resistant mechanism against it which is currently unknown 
(Ramirez-Garcia et al., 2018).  
1.5 Innate antifungal immunity 
 The innate immune system is the first line of defence against potentially fatal 
fungal infections. Macrophages and neutrophils (innate immune cells) are key 
phagocytes that mediate fungal killing (Erwig and Gow., 2016). Macrophages, a long-
lived monocyte-derived cells, are patrolling the tissue and epithelia to target microbial 
pray by chemotaxis. In comparison, neutrophils are short-lived, abundant and rapid 
responders of the innate immune system (Erwig and Gow., 2016). Another important 
phagocyte are dendritic cells, whose interaction with fungal cells leads to activation of 
adaptive immune system (Erwig and Gow., 2016). Phagocytic clearance of fungal 
pathogens depends on ingestion of invading fungi through recognition of surface 
structures that comprise the fungal cell wall. Those structures are called pathogen-
associated molecular patterns (PAMPs) and are recognised by structures on the 
surface of innate immune cells called pattern recognition receptors (PRRs). Fungal cell 
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wall is typically arranged in layers, such as chitin (the innermost layer); an N-
acetylglucosamine polymer; and external layer consisting of -1,3- and -1,6-glucans 
(Lionakis, Iliev & Hohl., 2017). Many fungal species also employ an -glucan layer (H. 
capsulatum); proteinaceous hydrophobin layer (A. fumigatus); N- O-linked mannans 
(C. albicans), glucuronoxylomannan, galctomannan capsule (C. neoformans) and 
melanin (A. fumigatus). Different layers of fungal cell wall are essential to immune 
detection as they consist of different PAMPs. Those are recognised by PRRs such as: 
C-type lectin receptors (CLRs), Toll-like lectin receptors (TLRs), nucleotide binding and 
oligomerization domain (NOD)-like receptors (NLRs) (Salazar & Brown., 2018).  
CLRs can recognise PAMPs such as:  
Dectin-1 (a -glucan receptor; which is known to be involved in the recruitment of the 
Syk kinase through immunoreceptor tyrosine-based activation motif (ITAM)-containing 
cytoplasmic domain that is phosphorylated by a Src family kinase). Dectin-1 can, in 
between, induce phagocytosis, respiratory burst, chemokine and cytokine production, 
and negatively regulate fungal-mediated neutrophil extracellular trap (NET) formation 
(Salazar & Brown., 2018).  
Dectin-2 cluster (clec6a = dectin-2, clec4d = MLC and clec4e = macrophage-inducible 
C-type lectin or Mincle) recognises -mannans and O-lined mannoproteins (Salazar & 
Brown., 2018). Those receptors drive intracellular signalling via Syk-CARD8 pathway. 
Its interaction with fungi can cause cytokine and ROS production and fungal killing.  
DC-specific intracellular adhesion molecule-3-grabing nonintegrin (DC-SIGN) 
recognises mannose-containing fungi and modulates signalling pathways, including 
signals induced from TLRs, therefore can induce adaptive immune responses 
depending on the nature of the pathogen (Salazar & Brown., 2018).  
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Mannose Receptor (MR) recognises carbohydrates terminated in D-mannose, L-fucose 
or N-acetyl glucosamine. MR are involved in phagocytosis, induce IL-17, increasing 
IL-10 and reducing pro-inflammatory cytokine production (Salazar & Brown., 2018).  
Additionally, there are other mannose-binding lectins such as galectins and mannose-
binding lectin (MBL). 
Toll-like receptors are inducing signalling pathway through adaptor proteins ((myeloid 
differentiation primary response 88 (MyD88); TIR domain-containing adapter-inducer 
interferon- - (TRIF)). TLR4 is known to recognise O-linked mannosyl residues and 
rhamnomannans inducing TNF- and IL-6 by macrophages; TLR2/TLR6 and 
TLR2/TLR1 are known to interact with phospholipomannan and glucuronoxylomannan 
to produce TNF- and nitric oxide by macrophages (Salazar & Brown., 2018). 
NLRs consist of subfamilies called NLRA, NLRB, NLRC and NLRP. NLRP3 is the best 
characterised, being involved in production of IL-1 and IL-18. Several yeast cell wall 
preparations shown to be able to activate NLRP3 which is involved in phagocytosis 
and inflammation (Salazar & Brown., 2018). 
Additional -Glucan receptors are complement receptor3 (CR3). This receptor 
mediates fungal phagocytosis and killing via complement-dependent manner as well 
as drive Th1 and Th17 responses (Salazar & Brown., 2018). 
 Once fungal pathogens are ingested, the harsh environment of the phagosome 
is thought to kill and eradicate the pathogen. To do so, the phagosome undergoes 
extensive remodelling which depends on the membrane fusion and fission of 
endosomal compartments (Erwig and Gow., 2016). Following that, the phagosomal 
lumen becomes acidified (via action of vacuolar ATPase proton pumps) and by 
activating oxidative- (the respiratory burst, reactive nitrogen intermediates) and non-
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oxidative mechanisms (antimicrobial peptides, hydrolases and lamination of nutrients) 
attempt to kill and destroy pathogen. This process is called phagosome maturation 
(Erwig and Gow., 2016). Above mentioned PAMPs define the contribution of PRRs 
involved in phagocytosis, downstream signalling pathway that mediates RAB function 
(RAB GTPases mediates the maturation of phagosome, a key proteins in this process) 
and outcome of the host-pathogen interaction (Erwig and Gow., 2016). Despite this 
beautiful and complex process, some fungal pathogens have developed a way to avoid 
phagosomal killing, by inhibiting phagosomal maturation, avoiding degradative 
environment or via escaping from the phagosome (Erwig and Gow., 2016). For 
instance, Candida albicans can neutralise the acidic pH of macrophage phagosome 
by extrusion of ammonia, similarly to Helicobacter pylori, which is able to produce 
ammonium from urea to buffer the phagosomal pH; C. albicans manipulates RAB 
GTPs (RAB14) to increase its survival within phagosome; C. neoformans is able to 
escape from phagosome via non-lytic expulsion “vomocytosis”, while A. fumigatus via 
cell-to-cell transfer “lateral transfer”; Histoplasma capsulatum inhibits accumulation of 
V-ATPase;  (Flannagan et al., 2012; Erwig and Gow., 2016; Shah et al., 2016; Gilbert 
et al., 2017). 
1.5.1 Host-pathogen interaction of innate immune cells with Mucormycetes, 
Scedosporium/Lomentospora and Fusarium spp.  
 The host-pathogen interaction with emerging fungal pathogens such as 
Mucormycetes, Scedosporium/Lomentospora and Fusarium spp. are very 
understudied and the resources of literature are still limited. However; some of the 
published studies are summarised below.  
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Macrophages  
 Studies of Kraibooj et al. (2014) on Lichtheimia corymbifera, belonging to 
Mucormycetes spp. have shown that different stages of spore activity (resting/dormant 
phase and swelling in size phase/increased metabolism) and opsonized spores, are 
better phagocytosed by macrophages in comparison to attenuated strain (strain that 
exhibited lower virulence) in the same conditions. They have also shown that 
opsonized spores of virulent strain are better phagocytosed in comparison to swollen 
and resting one; however opsonization had not effect on attenuated strain in 
comparison to swollen spores in terms of opsonization (Kraibooj et al., 2014). 
Mucormycetes spp. spores’ germination can be effectively inhibited by healthy murine 
bronchoalveolar macrophages, however; they fail to kill spore of R. oryzae; whereas, 
rabbit bronchoalveolar macrophages fungicidal activity against this strain greatly 
depends on spore developmental stage (Waldorf., 1989; Levitz et al.,1986). A recent 
study of Andrianaki et al. (2018) showed that primary macrophages are able to 
completely inhibit Mucormycetes growth and are susceptible to oxidative and non-
oxidative effector mechanisms of macrophages. Moreover, they showed that Rhizopus 
survival within macrophages is stimulated via melanin-induced phagosomal maturation 
arrest and iron homeostasis within macrophages impacts Mucormycetes survival 
within phagosome (Andrianaki et al., 2018). In comparison to Mucormycetes spp., 
macrophages have been shown not to be able to inhibit germination of ingested spores 
of Fusarium spp. Schafer et al. (2014) demonstrated that murine macrophages migrate 
towards and internalise germinated microconidia. They have also shown that survival 
of the macrophages that have engulfed germlings (germinated microconidia) depends 
on the number of engulfed fungal germlings (Schafer et al., 2014). 93.4% of 
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macrophages that internalized 4 or more germlings of F. oxysporum were killed by the 
fungus (Schafer et al., 2014), due to the ability of the fungal hyphae to grow inside the 
phagosome, leading to their escape and host-cell lysis.  
 One of first phagocytic cells to approach Scedosporium/Lomentospora are 
macrophages, which engulf conidia to prevent conidial germination (Gil-Lamaignere et 
al., 2003). Gil-Lamaignere et al. (2003) have shown that the conidia of two isolates of 
S. apiospermum (SA54A- isolate from heart biopsy from fatal disseminated infection, 
and SA1216- isolate from leg skin from localized subcutaneous, treated infection) can 
be phagocytosed by monocyte-derived macrophages (MDMs). The phagocytosis by 
human polymorphonuclear leukocytes (PMNs) and mononuclear leukocytes (MNCs) 
of conidia of both isolates was the same as in MDMs, however there were differences 
in interaction and susceptibilities of these two isolates to the oxidative burst response. 
SA54A- isolate exhibited generated higher oxidative burst production without relative 
hyphal damage suggesting its high level of resistance to oxidative burst then SA1216- 
isolate. 
 Chamilos et al. (2008 a) used Drosophila melanogaster to show that treatment 
with dexamethasone (steroid) impaired phagocytic efficacy against R. oryzae 
(belonging to Mucormycetes spp.) in comparison to healthy flies.  
 Voelz, Gratacap & Wheeler., (2015) research using zebrafish larva have shown 
importance of macrophages in response to Mucormycetes spp. in comparison to 
zebrafish larvae depleted in macrophages which showed higher mortality rate.  
 Vacher et al. (2015) research have shown that spores of Fusarium culmorum 
stimulates secretion macrophage inflammatory protein (MIP)-1, MIP-1, MIP-2, 
monocyte chemoattractant protein (MCP)-1, RANTES, IL-12p40, TNF-, IL-6, IL-
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12p70, IL-33, G-CSF and interferon gamma-induced protein (IP-10). Overall, 
macrophages have responded to F. culmorum releasing all those inflammatory 
proteins but not to its secreted components (mycotoxins). This suggest potential 
stimulation of innate immune system by this pathogen.  
 Neutrophils  
 A recent review by Ghuman & Voelz (2017) summarises the importance of 
neutrophils in interaction with Mucormycetes spp. Neutrophils have been shown to 
have a fungicidal activity against R. oryzae. Its NP-1 and NP-2 cationic peptides have 
been shown to be active against resting R. oryzae spores but not against swollen 
spores (Waldorf., 1989).  
 Chamilos et al. (2008 b) have shown that Rhizopus hyphae induce expression 
of pro-inflammatory genes of neutrophils (tnf- and il-1b). Similarly to Mucormycetes 
hyphae, Fusarium hyphae are also killed by neutrophils. Sun et al. (2010) showed that 
neutrophils are able to kill Fusarium via binding to fungal hyphae and secreting reactive 
oxygen species. They showed that TLR4 expression on neutrophils is necessary for 
recognition and killing of fusarial hyphae (Sun et al., 2010). Importantly, they have also 
shown that IL-1R1/MyD88 signalling regulated chemokine production and neutrophil 
recruitment during keratitis both trauma-induced and biofilm formation.   Taylor et 
al. (2014) research have also shown involvement of neutrophils in Fusarium killing and 
release of IL-17 by those.  Similarly, Tarabishy et al. (2008) showed that TLR4 is 
important for Fusarium spp. killing but not neutrophil recruitment. 
 Voelz, Gratacap & Wheeler., (2015) research using zebrafish larva have also 
shown the neutrophils being attracted to the site of Mucormycetes injection.  
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Dendritic cells (DCs) 
 Rhizopus spores do not activate DCs, in comparison, hyphae does stimulates 
release of IL-23 by DCs (Chamilos et al., 2010). They have shown that -glucan cell 
wall component of Rhizopus hyphae is necessary for IL-23 production and Th-17 
responses by DCs. In comparison, spores of Fusarium culmorum has been recognised 
by DCs via Dectin-1 receptor, but not MyD88 and TRIF-dependent TLR (Vacher et al., 
2015).   
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AIMS AND OBJECTIVES 
 The main aim of this project is to investigate novel treatments for trauma 
associated fungal pathogens. To achieve this aim, the host-pathogen interaction of 
such fungal pathogens was investigated in addition to assessing the effectiveness of 
alternative antifungal therapies.   
In the following chapters I will test (Figure 5): 
Acetic acid concentrations as a fungistatic and/or fungicidal treatment against trauma-
associated fungal species such as Mucormycetes, Scedosporium, Lomentospora, 
Fusarium, Candida and Cryptococcus spp. 
Blue light antifungal activity against Mucormycetes, Scedosporium, Lomentospora, 
Fusarium and Candida spp. 
Scedosporium, Lomentospora spp. interaction with innate immune cells. 
Ex-vivo skin model as a novel model to investigate pathogenicity of trauma associated 
fungal species. 
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Figure 1.5 Visualisation of objectives to develop novel approaches to treat 
trauma-associated fungal infections. 
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2. ACETIC ACID AS AN ANTIFUNGAL TOPICAL TREATMENT FOR TRAUMATIC 
INJURY INFECTIONS. 
 
Question 
Is acetic acid, a well known antibacterial treatment, effective against various genera 
and species of fungi associated with traumatic injury? Can this treatment be used as 
a topical treatment for fungal disease? 
 
The majority of the work presented in this chapter has been published in: 
Trzaska, W.J. et al. (2015) pH manipulation as a novel strategy for treating 
mucormycosis. Antimicrob Agents Chemother, 59, 6968-6974. 
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2.1 Introduction 
 Acetic acid has been used for thousands of years as an antimicrobial agent. 
During the American Civil War and World War I, apple cider vinegar was used as a 
wound dressing, whilst during the great plagues of Europe, thieves used vinegar to 
avoid catching infection when stealing valuables from the dead bodies of plague 
victims (Fraise et al., 2013). More recently, it has been used to treat burn wound 
infections, and has shown activity against various bacterial pathogens (Ryssel et al., 
2009; Nagoba et al., 2013). In addition, it is commonly used for eliminating bacteria 
from fresh products, or curing acute otitis externa (Cortesia et al., 2014). Ryssel et al. 
(2009) tested acetic acid activity against common bacterial strains found in burn 
patients and showed successful inhibition of multi-drug-resistant P. aeruginosa and A. 
baumannii. Acetic acid was also found to be bacteriostatic against multiple antibiotic 
resistant strains of P. aeruginosa at concentrations as low as 0.5-5 % (Nagoba et al., 
2013). Levine and Fellers (1940) compared the efficacy of acetic, lactic and 
hydrochloric acid against Salmonella typhimurium, Saccharomyces cerevisiae, and 
Aspergillus niger, their research showed that acetic acid is more toxic to those 
organisms then lactic or hydrochloric acid. The mechanism of acetic acid action against 
bacteria, fungi and yeast remains unknown. Although historically attributed to pH 
(Kahlenberg and True, 1896) more recent work (Higgins and Brinkhaus, 1999) has 
stated that the mechanism of inhibition of microbial growth by organic acids is not 
considered to be a pH phenomenon. Cottier et al. (2015 a) investigated the 
transcriptional response of C. albicans to weak organic acids such as acetic, lactic, 
propionic and butyric acids. During the physiological response of C. albicans to weak 
acids, 16 genes were identified to play an important role (Cottier et al., 2015 a). Several 
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lines of research have shown that iron uptake has an important role of fungal response 
to weak acids (Mira et al., 2010; Cottier et al., 2015 a). Cottier et al., (2015 a) suggested 
RNA synthesis and ribosome biogenesis genes as a pathway regulated in response to 
such treatment. Since chronic exposure of C. albicans to weak organic acids down-
regulated of RNA synthesis and ribosome genesis genes, significantly reducing total 
level of RNA.  Cottier et al. (2015 b) also demonstrated a role for MIG1, a single gene, 
which confers weak acid resistance. This gene was previously known for its role in 
glucose repression, and now, Cottier et al. (2015 b), has confirmed its role in resistance 
to acetic, propionic, butyric and lactic acids.  
 The fungal species such as Mucormycetes, Scedosporium, Fusarium and 
Candida are commonly associated with traumatic injuries. Current topical treatment for 
wound infections is very expensive and often ineffective (Drosou et al., 2003). 
Therefore, there is an urge for developing novel treatments that are cheap, accessible 
and effective across different fungal species. Therefore, we have investigated here the 
antifungal activity of acetic acid and showed that fungal spores treated with acetic acid 
undergo rapid acidification of their cytoplasm and become arrested without 
germination. Thus, we propose that early application of dilute acetic acid may 
represent an effective and low-cost strategy to minimize trauma-associated fungal 
infections in traumatic wounds. 
 
 
 
 
  43 
2.2 Materials and Methods 
Unless otherwise stated all reagents were purchased from Sigma Aldrich UK. 
 Strains used in experiments. Lichtheimia corymbifera 9.6002134 and 
Rhizopus microsporus 12.6652333 (clinical isolates), Mucor circinelloides NRRL3631 
and Mucor circinelloides CBS277.49 (Li, et al., 2011); Scedosporium apiospermum 
IHEM 14462 and Scedosporium (Lomentospora) prolificans IHEM5608; Fusarium 
oxysporum IHEM 25499 and Fusarium solani IHEM 6092; two isolates of Cryptococcus 
neoformans, H99 and KN99 (Nielsen et al., 2003); C. albicans SN152 (Noble and 
Johnson, 2005) and C. albicans DAY286 (Nobile and Mitchell, 2009). All 
Mucormycetes strains were grown on Sabouraud agar plates (VWR) for at least 10 
days before use. All Scedosporium, Lomentospora and Fusarium strains were grown 
on Potato Glucose agar plates for at least 10 days before use. Cryptococcus spp. and 
Candida spp. were grown on YPD agar plates for 2 days, then grown over night in YPD 
broth, rotating at 25° C before use. 
 Media. Acetic acid experiments were performed in Sabouraud broth (Fisher 
Scientific) for Mucormycetes, Scedosporium, Lomentospora and Fusarium spp., and 
YPD broth for Cryptococcus and Candida spp. with different concentrations of acetic 
acid (Table 1). For hydrochloric and lactic acid treatments, the relevant pH in 
Sabouraud broth was matched with the pH generated by the different concentrations 
of acetic acid.  Spores of Mucormycetes, Scedosporium, Lomentospora and Fusarium 
spp. were washed with PBS (Fisher Scientific), spun down and re-suspended in PBS 
for cell counting in a haemocytometer. Spore counts were adjusted to a final count of 
1 x 104 cells per ml.  Candida and Cryptococcus cells were grown over night in YPD 
broth prior to experiment, counted and adjusted to final count of 5 x 105 cells per ml.  
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 Fungal growth inhibition assays for Mucormycetes. 5 % acetic acid 
(Tayside Pharmaceuticals, Dundee, UK) was serially diluted into Sabouraud media to 
produce concentrations of 2.5 %, 1.25 %, 0.63 %, 0.31 %, 0.16% and 0.08 %. The pH 
of each of these concentrations of acetic acid was measured and then pH-matched 
solutions of hydrochloric acid or lactic acid were produced in Sabouraud (Table 1).  For 
pH-neutralised experiments, media were generated as above but then 1M NaHCO3 
was added to return the pH to that of the control. Fungal growth rate was measured by 
OD600 reading at time 0 (time of spore inoculation to acetic acid), and after 24 and 48 
hours using a microplate reader (BMG Labtech). Plates were incubated at 37 C in 
between reads, without shaking. To estimate spore killing, samples from the 
concentrations of acetic acid in which no growth was observed were plated onto 
Sabouraud agar plates, and the number of colony forming units (CFU) were counted 
24 hours later.   Each experiment was performed with at least three experimental 
replicates and three biological repeats. 
 Fungal growth inhibition assays for Scedosporium, Lomentospora, 
Fusarium and Candida spp. 5 % acetic acid was serially diluted into Sabouraud 
media for Scedosporium, Lomentospora and Fusarium, and in YPD broth for Candida 
to produce concentrations of 2.5 %, 1.25 %, 0.63 %, 0.31 %, 0.16 % and 0.08 %. And 
then 0.8 %, 0.4 %, 0.2 % and 0.1 % for Scedosporium, Lomentospora and Fusarium 
spp. Time-lapse imaging was performed on fungal spores using a Nikon Eclipse Ti 
microscope with ELWD 0.52NA 20x Ph1 objective for 18-20 hours, in 37 C, humidified 
with no CO2.  Movies were analysed and prepared using NIS Elements software. Each 
experiment was performed with at least two experimental replicates. 
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 Fungal growth inhibition assays for Cryptococcus. To estimate spore 
killing, fungal cells were incubated in the concentrations of acetic acid of 5 %, 2.5 %, 
1.25 %, 0.8 %, 0.6 %, 0.4 %, 0.3 %, 0.2 %, 0.16 %, 0.1 %, 0.08 % for 48 hours, then 
were plated onto YPD agar plates, and the number of colony forming units (CFU) were 
counted 24 hours later.   Each experiment was performed with at least three 
experimental replicates.  
 Time lapse imaging for germinated Mucormycetes. Time-lapse imaging was 
performed on fungal spores either prior to, or shortly after germination, using a Nikon 
Eclipse Ti microscope with LWD 0.52 20x objective for 18 hours in 37 C, humidified 
with no CO2.  Movies were analysed and prepared using NIS Elements software. 
 Time of action for acetic acid killing of Mucormycetes. To test how rapidly 
acetic acid impacts on fungal viability, spores were incubated for 0, 15, 30, 60, 120, 
180, 240 and 300 minutes in 2.5 % acetic acid in cRPMI (media to mimic blood 
environment)  (complete RPMI media 1640 (cRPMI) - phenol free (GIBCO) + 100 U/ml 
of Penicillin and 100 U/ml of Streptomycin, 2 mM of L-glutamine and 10% FBS and 
then plated onto Sabouraud plates for subsequent colony counting 24 hours later.  
Scoring for colony forming units at this early time point requires more careful 
observation but avoids problems of extensive filamentation, leading to “fused” 
colonies. 
 Measurement of pHi. To determine intracellular pH (pHi). Fungal spores at 
a concentration of 6 x 10
6
/ml were incubated in RPMI medium at 37° C and 5 % CO2 
for 4 h before imaging. Cells were then incubated with 5 μM BCECF-AM [2’,7’-bis-(2- 
carboxyethyl)-5-(and-6)-carboxyfluorescein, acetoxymethyl ester; Life Technologies, 
USA] (which is used to estimate vacuolar and internal pH) for 1 h and resuspended in 
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fresh medium to allow full deesterification of the dye. Intracellular pH was measured 
via single-cell ratiometric imaging at x60 magnification using an Olympus IX81 
(Olympus, United Kingdom) coupled to a monochromator-based illumination system 
(Cairn Research, United Kingdom) and an Evolve 512 EMCCD (Photometrics, USA) 
digital camera; image acquisition was controlled using MetaFluor (Molecular devices, 
USA) acquisition software. Fluorescence emission for excitation wavelengths centered 
at 490 nm and 436 nm was captured at 530 nm, and ratios were obtained for individual 
cells after background subtraction. Ratios were converted to intracellular pH values 
after in situ calibration as described by James-Kracke, 1992. Briefly, after the initial 
germination stage, cells were permeabilised in RPMI supplemented with 100 μM 
nigericin (Thermofisher Scientific) and 150 mM KCl and subsequently exposed to 
extracellular pH ranging from 4.5 to 7.5 (acetic, lactic and hydrochloric acids). BCECF-
AM (Thermofisher Scientific) ratios were then converted to intracellular pH (pHi) values 
using the following equation: 
𝑝𝐻𝑖 =  𝑝𝐾𝑎 −  𝑙𝑜𝑔 [
(𝑅𝑚𝑎𝑥 
− 𝑅)
𝑅 − 𝑅𝑚𝑖𝑛
×
𝐹𝑏𝑎𝑠𝑒436
𝐹𝑎𝑐𝑖𝑑436
]   
Where pKa is the acid dissociation constant for BCECF-AM, R is the ratio of the 
emission fluorescence signals measured at 530 nm when the fluorophore is excited at 
490 nm and 436 nm, respectively, Rmax is the ratio for maximum fluorescence 
measured at pH 7.5, Rmin is the ratio for minimum fluorescence measured at pH 4.5, 
and Fbase436/Facid436 is the ratio of fluorescence signals at 436 nm under the basic 
and acid conditions used to obtain Rmax and Rmin. 
 Statistical analysis. Statistical analysis was conducted using two-way ANOVA 
with Dunnett’s multiple comparison test. *p < 0.05, **p < 0.01, ***p < 0.001. 
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2.3 Results 
Acetic acid shows strong antifungal activity against Mucormycetes species.  
 Ubiquitous fungal spores are the infectious agent for mucormycosis. This 
disease depends on germination of fungal spores with subsequent tissue invasive 
hyphal growth. To test whether spore germination of Mucormycetes was inhibited by 
acetic acid, spores of Rhizopus microsporus 12.6652333, Lichtheimia corymbifera 
9.6002134 and Mucor circinelloides NRRL3631 and CBS277.49 (Li et al., 2011), were 
inoculated into Sabouraud broth (to mimic nutrient-rich conditions) with varying acetic 
acid concentrations. Mucormycetes grow as filamentous fungi and thus OD 
measurement is problematic for monitoring growth rates, but is very successful in 
monitoring the onset of germination. Acetic acid impaired germination in all isolates at 
concentrations as low as 0.3 % (Figure 2.1 & 2.2).  To test whether this effect was 
fungistatic or fungicidal, spores were plated onto Sabouraud agar plates and the 
number of colonies was counted after 24 hours. At concentrations of 2.5 % and above 
no viable colonies could be recovered (Figure 2.3).  Time course analysis indicated 
that this fungicidal activity peaks following approximately four hours of exposure to 2.5 
% acetic acid (Figure 2.4). Thus acetic acid strongly suppresses fungal germination at 
very low concentrations and is potently fungicidal at concentrations above 2.5 %.  
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Figure 2.1 Acetic acid shows strong antifungal activity against several species 
of Mucormycetes. 
Acetic acid inhibits fungal spore germination. Spores were grown in sabouraud media 
and growth assessed by OD600 nm measurements. Graphs show OD measurement 
after 24 (A) and 48 (B) hours. Error bars represent standard deviation (n=4, three 
experimental replicates at each time). Statistical analysis was conducted using two-
way ANOVA with Dunnett’s multiple comparison test. *p < 0.05, **p < 0.01, ***p < 
0.001. 
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Figure 2.2 Visualization of acetic acid activity against R. microsporus. 
Time-lapse imaging shows acetic acid concentrations of 0.16 % strongly inhibit 
germination. Acetic acid percentage (%) is presented in the top left corner of each 
image.  
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Figure 2.3 High concentrations of acetic acid are fungicidal. 
Acetic acid is fungicidal to spore at concentrations of 2.5 % and above. Spores were 
grown in Sabouraud media supplemented with different concentrations of acetic acid 
for 24 and 48 hours and then plated for colony-forming unit (CFU) counts. Graphs 
show percentage survival related to untreated. Error bars represent standard deviation 
(n=3, three technical replicates at each time) and statistical analysis was conducted 
using two-way ANOVA with Dunnett’s multiple comparison test in which spore survival 
in different concentrations of acetic acid for each strain was compared to 0.3 % 
treatment.  *p < 0.05, **p < 0.01, ***p < 0.001. There was no 0 % (control samples) 
included in this study as an experimental error. 
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Figure 2.4 Time course showing activity of 2.5 % of acetic acid. 
The fungicidal activity of 2.5 % acetic acid requires prolonged incubation. Spores were 
grown in RPMI media supplemented with 2.5 % acetic acid and plated onto sabouraud 
agar plates every 15, 30, 60, 120, 180, 240 and 300 minutes. The number of colonies 
was counted 24 hours later. Error bars represent standard deviation (n=3, three 
experimental replicates at each time) and statistical analysis was conducted using two-
way ANOVA with Dunnett’s multiple comparison test (compared to 0 min). *p < 0.05, 
**p < 0.01, ***p < 0.001.  
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Antifungal activity against Mucormycetes is not seen with other acids. 
 To investigate whether this effect is driven solely by environmental pH, we 
performed similar experiments using an alternative organic acid (lactic acid) and an 
inorganic acid (hydrochloric acid). The pH of sabouraud media seen at different 
concentrations of acetic acid was matched with either hydrochloric or lactic acids 
(Table 2.1) and monitored for spore germination. Neither hydrochloric nor lactic (Figure 
2.5) acids significantly inhibited spore germination other than at the very lowest pHs. 
Thus, the antifungal effect of acetic acid is not simply a reflection of lowered 
environmental pH.  
 
Acetic acid in sabouraud media Acetic acid in RPMI media 
Percentage pH Percentage pH 
5 2.52 5 2.32 
2.5 3.27 2.5 3.19 
1.25 3.63 1.25 3.67 
0.63 3.92 0.63 4.03 
0.31 4.18 0.31 4.46 
0.16 4.43 0.16 5.24 
0.08 4.68 0.08 6.32 
Sabouraud 
(control) 
5.73 RPMI (control) 7.45 
Table 2.1 pH of acetic acid in media.  
pH of acetic acid in either Sabouraud (left) or RPMI (right) media. 
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Figure 2.5 Lack of inhibition of spore germination by other acids. 
Other acids are less effective at inhibiting spore germination. Neither hydrochloric (A-
B) nor lactic (C-D) acids are able to inhibit spore germination as effectively as acetic 
acid. Spores were grown in sabouraud media with addition of either hydrochloric (A-B) 
or lactic (C-D) acids and growth assessed by OD 600nm measurements. Graphs show 
OD measurements after 24 and 48 hours. Error bars represent standard deviation 
(n=3, three experimental replicates at each time) and statistical analysis was 
conducted using two-way ANOVA with Dunnett’s multiple comparison test.  *p < 0.05, 
**p < 0.01, ***p < 0.001.  
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Growth inhibition by acetic acid involves both pH and acetate dependent effects.   
 To test a potential pH-independent effect of acetic acid, we neutralised different 
concentrations of acetic acid by adding NaHCO3 to return the pH to that of the control, 
but retaining the presence of free acetate.  These pH-neutralized media continued to 
inhibit spore germination (Figure 2.6) less effectively than non-neutralized acetic acid, 
but more effectively than other acids.  Thus, the suppression of fungal germination by 
acetic acid involves pH-dependent and pH-independent, but acetate-dependent, 
mechanisms. 
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Figure 2.6 Neutralised acetic acid solutions still inhibit fungal germination. 
Neutralized acetic acid inhibits fungal spore germination with moderate efficacy. 
Spores were grown in sabouraud media with different concentrations of acetic acid 
adjusted to pH 5.6 with sodium bicarbonate and growth assessed by OD 600nm 
measurements. Graphs show OD measurements after 24 (A) and 48 (B) hours. Error 
bars represent standard deviation (n=3, three experimental replicates at each time) 
and statistical analysis was conducted using two-way ANOVA with Dunnett’s multiple 
comparison test. *p < 0.05, **p < 0.01, ***p < 0.001. 
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Acetic acid inhibition of spore germination is not solely due to reduced 
intracellular pH.  
 To investigate the mechanism by which acetic acid inhibits spore germination, 
we measured (experiment performed by Dr. Joao N. Correia) the intracellular pH of 
fungal spores during exposure to acetic, hydrochloric, and lactic acid. Cells were 
incubated with the pH-responsive BCECF-AM dye and monitored following acid 
exposure. At identical extracellular pHs, acetic acid lowered intracellular pH more 
strongly than hydrochloric or lactic acids, likely due to stronger dissociation of the ions 
within the fungal cytoplasm (Figure 2.7). However, even at identical intracellular pHs, 
acetic acid is far more effective at inhibiting fungal germination, suggesting that this 
inhibition is not solely due to the raised intracellular hydrogen ion concentration (e.g., 
compare growth inhibition by 0.3 % acetic acid in Figure 2.1 with growth inhibition by 
hydrochloric acid at pH 3.56 in Figure 2.5, both of which drive an intracellular spore pH 
of 5.9, as shown by the results in Figure 2.7). 
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Data produced by Dr. Joao N. Correia (University of Birmingham, May lab) 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.7 Intracellular pH measurement in R. microsporus. 
Intracellular pH measurements following treatment with different acids and, following 
experimentation, upon return to neutral pH via a wash with buffered medium. Spores 
were grown in RPMI medium supplemented with different acids. The intracellular pH 
was measured using the calibrated ratiometric analysis of the BCECF-AM dye 
described in Materials and Methods. Error bars represent standard errors of the means 
(n = 3, with three experimental replicates at each time point); statistical analysis was 
conducted using two-way ANOVA with Dunnett posttest. ***, P < 0.001. 
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Acetic acid shows activity against actively growing Mucormycetes.  
 In a clinical setting, Mucormycetes spores may have germinated before 
treatment can be initiated.  Thus, to investigate whether acetic acid is active on 
germinated spores filamentously growing fungal cells were monitored by time-lapse 
microscopy and then exposed to different concentrations of acetic acid (Figure 2.8). 
As with non-germinated spores, growing fungi were strongly inhibited by acetic acid 
concentrations as low as 0.3 % (Figure 2.8).  Thus, acetic acid is effective even on 
spores that have already germinated.  
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Figure 2.8 Acetic acid antifungal activity on germinating spores. 
Time-lapse imaging shows prolonged inhibition of further fungal growth in germinated 
spores at acetic acid concentrations of 0.3 % or above. Acetic acid percentage (%) is 
presented in the corner of each image.  
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Acetic acid shows strong antifungal activity against Scedosporium, 
Lomentospora and Fusarium species.  
 Scedosporium, Lomentospora and Fusarium fungal spores are the infectious 
agents for scedosporiosis and fusariosis respectively. To test whether spore 
germination of Scedosporium, Lomentospora and Fusarium was inhibited by acetic 
acid, spores of Scedosporium apiospermum IHEM 14462 and Lomentospora 
(Scedosporium) prolificans IHEM5608; Fusarium oxysporum IHEM 25499 and 
Fusarium solani IHEM 6092, were inoculated into sabouraud broth (to mimic nutrient-
rich conditions) with varying acetic acid concentrations. Time-lapse imaging was 
performed on fungal spores to verify fungal inhibition of germination by acetic acid 
(Figure 2.9-2.12).  
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Figure 2.9 Visualization of acetic acid activity against S. apiospermum IHEM 
14462. 
Time-lapse imaging shows acetic acid concentrations of 0.4 % strongly inhibit 
germination. Acetic acid percentage (%) is presented in the corner of each image.  
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Figure 2.10 Visualization of acetic acid activity against L. prolificans IHEM 5608. 
Time-lapse imaging shows acetic acid concentrations of 0.4 % strongly inhibit 
germination. Acetic acid percentage (%) is presented in the corner of each image.  
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Figure 2.11 Visualization of acetic acid activity against F. oxysporum. 
Time- lapse imaging shows acetic acid concentrations of 0.01 % strongly inhibit 
germination. Acetic acid percentage (%) is presented in the corner of each image.  
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Figure 2.12 Visualization of acetic acid activity against F. solani. 
Time-lapse imaging shows acetic acid concentrations of 0.04% strongly inhibit 
germination. Acetic acid percentage (%) is presented in the corner of each image.  
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Acetic acid shows strong antifungal activity against Candida and Cryptococcus 
species.  
 First, the concentration of acetic acid that kills Cryptococcus and Candida cells 
were tested. For Cryptococcus spp., fungal cells were incubated in different acetic acid 
concentrations and then plated on agar plates for CFU counting. The results show that 
concentration of acetic acid as low as 0.4 % killed Cryptococcus cells (Fig. 2.15). For 
Candida spp. cells were inoculated in different acetic acid concentrations and observed 
under time-lapse microscopy. The results show that for both isolates of C. albicans 
SN152 and DAY286 tested, acetic acid concentrations as low as 0.3 % are sufficient 
to inhibit fungal growth (Fig. 2.13-2.14).  
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Figure 2.13 Visualization of acetic acid activity against C. albicans SN152. 
Time-lapse imaging shows acetic acid concentrations of 0.3 % strongly inhibit growth. 
Acetic acid percentage (%) is presented in the corner of each image.  
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Figure 2.14 Visualization of acetic acid activity against C. albicans DAY286. 
Time-lapse imaging shows acetic acid concentrations of 0.3 % strongly inhibit growth. 
Acetic acid percentage (%) is presented in the corner of each image.  
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Figure 2.15 C. neoformans H99 and KN99 strains survival after acetic acid 
treatment. 
CFU counting shows that 0.4 % of acetic acid is fungicidal to both strains of C. 
neoformans tested. Yeast cells were grown in YPD media for 48 hours supplemented 
with different concentrations of acetic acid and plated onto YPD agar plates. Number 
of colony forming units was counted 24 hours later. Error bars represent standard 
deviation (n=3, three experimental replicates at each time) and statistical analysis was 
conducted using two-way ANOVA with Dunnett’s multiple comparison test. *p < 0.05, 
**p < 0.01, ***p < 0.001.  
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2.4 Discussion 
 In this chapter I have described the fungistatic and fungicidal properties of acetic 
acid against several Mucormycete, Scedosporium, Lomentospora, Fusarium, Candida 
and Cryptococcus species.  
 Fungal infections are a common complication of traumatic injuries sustained in 
both military and civilian environments like agricultural, motor vehicle, and natural 
disasters or blunt crush injuries (Warkentien et al., 2012). All trauma-associated fungal 
infections caused by fungi tested in this project are a cause of life-threating infection, 
with high mortality rates (Church et al., 2006; Evriviades et al., 2010; Warkentien et al., 
2012). Whilst susceptible patient groups (e.g. those with impaired immunity and 
traumatic injuries) are increasing, diagnosis is often delayed and antifungal therapy 
typically ineffective and expensive (Pfaller and Diekema, 2004; O'Donnell et al., 2008; 
Lackner et al., 2012). Moreover, fungal tissue infections are very difficult to treat as 
many of these species show intrinsic resistance to antifungals and drug accessibility 
to wounded tissue is poor (Wuthisuthimethawee et al., 2015).  Hence, there is a need 
for prompt, prophylactic treatment for high-risk patients (e.g. severely injured patients). 
Thus, acetic acid represents a novel, potentially powerful strategy for dealing with such 
infections.  
 Here we have tested and demonstrated that very low concentrations of acetic 
acid inhibit spore germination and yeast growth. Levine and Fellers (1940) early 
studies on food spoilage microorganisms such as S. aureus, B. cereus, S. cerevisiae 
or A. niger, suggested that toxicity of acetic acid is not only due to the dissociated 
hydrogen ion alone but also seems to be functioning in conjunction with the 
undissociated acid. Our results support these observations, showing that acetic acid 
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is more fungistatic and fungicidal than other acids tested (hydrochloric and lactic, 
inorganic and organic acids respectively) even if matched for extracellular and 
intracellular pH. Here, we have investigated by measuring intracellular pH of fungal 
spores treated with different acids, and by neutralising acetic acid pH have shown that 
the antifungal effect of acetic acid is not simply a reflection of lowered environmental 
pH. Therefore, we propose that the antifungal activity of acetic acid is a function of both 
undissociated acid and/or free acetate, together with the reduced pH driven by the 
dissociated hydrogen ions. As undissociated acid molecules diffuse through the cell 
membrane, they dissociate further within the cytoplasm. Thus, the fungus must expend 
energy both to pump out excess protons and to deal with free acetate (salt) within the 
cytoplasm.  
 Clinically, there are considerable benefits in using acetic acid; it is a cheap 
compound that is non-hazardous and temperature stable. It shows great potential to 
be used as a topical antifungal treatment in those challenging clinical situations where 
application to wounded tissue is difficult, for instance, in dressings for military 
personnel.  
 As it works at very low concentrations there is a very low risk of patient 
discomfort or adverse effect. Currently, 2.5 % of acetic acid is being used to treat 
bacterial infections in burn wound patients (Halstead et al., 2015). We showed that 
even low percentage (0.3 %) is very effective against all fungal infections tested in this 
research. Thus, our data presents acetic acid as a low-cost, effective and rapid 
treatment for a variety of trauma-associated, skin fungal infection. However, this 
research has strictly focused on external treatment. Currently there is no acetic acid 
form available that it could be used intravenously or orally. This holds limitations of the 
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treatment. Therefore, there is a need to investigate and develop acetic acid compound 
that could be used as an internal treatment of fungal and bacterial infections in the 
future.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  74 
3. BLUE LIGHT AS A NOVEL ANTIMICROBIAL TREATMENT OF WOUND 
INFECTIONS 
 
 
Questions 
Is blue light antimicrobial against trauma associated fungal species? Can it be use as 
a treatment of traumatic injury infected with fungal species? 
 
 
The majority of this chapter has been published in  
Trzaska, W.J. et al. (2017) Species-specific antifungal activity of blue light. Sci Rep, 7, 
4605. 
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3.1 Introduction 
 It is well known that light (in particular blue light) plays an important role as an 
environmental signal for fungi, such as in growth regulation, sexual or asexual 
reproduction, or pigment formation (Idnurm and Heitman, 2010). Neurospora crassa is 
a model for investigating light sensing in fungi (Chen, Dunlap and Loros, 2010) and 
work in this species has identified WC-1, WC-2 and VIVID as the primary blue light 
photoreceptors (Corrochano, 2007). Blue light is a wavelength of light that is the most 
effective in fungal photomorphogenesis, and Darwin first reported its response in 
plants in 1881, proposing that plants could grow differentially in response to external 
stimuli, such as light or gravity (Purschwitz et al., 2006).  
 However, blue light can also suppress or inactivate bacteria or fungi (Yin et al., 
2013). Different light wavelengths combined with photosensitising dyes have been 
shown to be very effective against various bacteria, fungi, mycoplasma and viruses 
(Lembo et al., 2009). Such a combination is called photodynamic therapy (PDT). The 
principle of PDT is to introduce a photosynthetic agent to the patient that is activated 
and utilized by light in the presence of oxygen (Sudhakara et al., 2012). However, a 
major limitation for PDT is the need to introduce exogenous photosensitisers inside the 
pathogen (Zhang et al., 2014). However, several side effects have been reported due 
to an inappropriate drug type and dose, light wavelength and toxicity (Sudhakara et 
al., 2012).  
 Light has also been used in medicine for treatment of psychiatric conditions, 
such as dementia, seasonal affective disorder or circadian rhythm sleep disorders; for 
treatment of arthritic pain and cancer (Shirani and St Louis, 2009; Tafur et al., 2010). 
 Therefore, blue light has become an interesting tool for many researchers as an 
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antimicrobial treatment and its effectiveness against pathogens that does not require 
any exogenous photosensitizers. Zhang et al., (2014) have shown that both 
Acinetobacter baumannii and Candida albicans (Zhang et al., 2016) are susceptible to 
blue light treatment in a mouse burn model. Importantly, the authors also showed that 
microbes are more susceptible to blue light than keratinocytes, suggesting its 
advantage to use over other currently used topical treatments such as povidone iodine 
or hydrogen peroxide that are often toxic and ineffective (Drosou et al., 2003). Other 
pathogens, such as Trichophytom rubrum and Trichophytom mentagrophytes 
(Moorhead et al., 2016); Helicobacter pylori (Lembo et al., 2009); Artemisia vulgaris 
(Gold et al., 2009); Bacillus cereus, Clostridium difficite (Vatansever et al., 2013); 
Staphylococcus aureus and Pseudomonas aeruginosa (Dai et al., 2012); and more, 
have also shown susceptibility to blue light treatment.   
 The proposed mechanism behind the antimicrobial action of blue light is its 
ability to activate endogenous porphyrins within cells, which causes their 
photoexcitation, resulting in production of ROS and cell death (Moorhead et al., 2016). 
Porphyrin molecules, presented within the cell, absorb the light energy and become 
excited to the triplet state. Then, the excited photosensitizer interacts with either triplet 
oxygen, single oxygen or cell components to form free radicals and radicals’ ions 
(Ramakrishnan et al., 2016). 
 Here we tested antifungal activity of blue light against trauma associated fungal 
species. Some of them such as Mucormycetes or Scedosporium and Lomentospora 
spp. have not been tested before. We have investigated whether blue light treatment 
would be a suitable approach to treat fungal infected wounds caused by traumatic 
injuries. We have shown that 60 min blue light treatment (equivalent to 216 J/cm2) has 
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species-specific antifungal activity against Mucormycetes, Scedosporium, 
Lomentospora, Fusarium and Candida spp. tested.  Moreover, we have presented that 
blue light induce morphological switching from hyphae growth into yeast-like growth in 
Mucormycetes, and their enhanced survival following treatment. Additionally, we have 
noticed increased temperature produced by the blue light machine during treatment. 
 Therefore, we propose that the blue light approach is associated with more 
challenges, as our data suggest that it can have both positive and negative impacts on 
patient outcome, depending on the infecting species. This requires proper diagnosis 
prior to treatment. 
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3.2 Materials and Methods 
Unless otherwise stated all reagents were purchased from Sigma Aldrich UK. 
Fungal strains.  
 Eight different strains were tested. Rhizopus microsporus 12.6652333 
(clinical isolate) and Mucor circinelloides NRRL3631 (Li, et al., 2011), Scedosporium 
apiospermum IHEM 14462, Scedosporium prolificans IHEM 5608, Fusarium 
oxysporum IHEM 25499, Fusarium solani IHEM 6092, all from the Belgian Coordinated 
Collections of Microorganisms, as well as Candida albicans SN152 (Noble and 
Johnson, 2005) and Candida albicans DAY 286 (Nobile and Mitchell, 2009) 
Mucormycetes strains were grown on Sabouraud agar plates (VWR), Scedosporium 
and Fusarium spp. were grown on Potato Glucose agar plates for at least 10 days at 
room temperature before use, and Candida spp. were grown on Yeast Extract Peptone 
agar plates for 2 days at 37° C, then grown over night in YPD broth before use. 
 Temperature measurement. The temperature of treated fungal suspension 
was measured within 24 well plates or 25 ml glass conical flasks using a submersible 
aquarium thermometer (ETI, UK). The temperature on media was recorded throughout 
treatment.  
 Treatment with blue light.  A LED flood array, composed of 144 LEDs (Henkel-
Locite, Hemel Hampstead, UK), was used to treat a 10 x 10 cm area using high-
intensity blue light (405nm).  All experiments on fungal cells were performed by placing 
samples within the treatment area for 1 hour, providing an equivalent total dosage of 
216 J/cm2. Dose J/cm2 = Irradiance (W) x exposure time (seconds). To control for 
temperature effects, experiments were either performed in a cold room (4° C) or at 
room temperature, as indicated.  Spores were washed off the agar plates with 
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phosphate-buffered saline (PBS) (Fisher Scientific), then spun down 1000 x g/ 3 min/ 
maximum braking, and resuspended in PBS for cell counting in a haemocytometer. 
Then, 1 x 104 / ml of fungal spores were inoculated into PBS and placed under the 
treatment area for 60 minutes. Two control conditions were used; one 24 well multi-
well plate covered with aluminum foil inside the blue light machine (exposed to 
temperature, but not blue light) and another 24 well multi-well plate kept outside the 
instrument during operation (not exposed to either raised temperatures or blue light). 
Following treatment, each fungal suspension was transferred onto appropriate agar 
plates and CFU numbers were counted following growth (typically a few days later). 
Each experiment was performed in technical triplicate and repeated on at least three 
occasions. For determining an effect of blue light on fungal morphology assay, fungal 
spores were inoculated onto agar and treated with blue light for 1 hour in the cold room 
(including foil and room control plates), then left to grow for a few days.  
 Time-lapse imaging. Time-lapse imaging was performed on fungal spores 
immediately after treatment with blue light, using a Nikon Eclipse Ti microscope with 
an extra-long working distance (ELWD) 0.53 20x Ph1 objective camera, in an 
environmental chamber at 37° C, with no CO2 for 18 h.  Movies for publication were 
analysed and prepared in NIS Element software (Nikon). For microscopy experiments, 
fungal spores were inoculated in Sabouraud broth (Scedosporium, Lomentospora and 
Fusarium spp.) and YPD broth for Candida spp.  
 Light controls for R. microsporus. Light controls for R. microsporus and M. 
circinelloides NRRL3631 were performed on fungal spores that were washed of the 
agar plates, inoculated in Sabouraud broth and covered with aluminum foil or exposed 
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to light. Plates were incubated in room temperature for 10 hours and samples were 
taken for imaging. 
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3.3 Results 
Blue light shows antifungal activity against some, but not all, fungal species 
tested.  
 For most fungal infections the initiating inocula are fungal spores and disease 
progression depends on germination and subsequent hyphal invasion of tissue.  We 
therefore exposed spores of six common trauma-associated fungal pathogens 
(Rhizopus microsporus, Mucor circinelloides, Scedosporium apiospermum, 
Lomentospora (Scedosporium) prolificans, Fusarium oxysporum, Fusarium solani) to 
blue light treatment and then transferred onto agar plates for CFU counting over the 
following days.  Blue light was highly effective against Scedosporium, Lomentospora 
and Fusarium species, but showed no inhibitory effect (but rather enhanced survival 
relative to controls) on the two species of Mucormycetes tested (Figure 3.1).   
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Figure 3.1 60 min (216 J/cm2) blue light treatment of fungal spores. 
Spores were inoculated in PBS and treated with blue light and then plated onto 
appropriate agar plates for enumeration (A).  Alternatively, 1000 spores were plated 
onto agar and then exposed to blue light for 60 minutes before being incubated for 
growth (B) Error bars represent standard deviation (n=3, with three biological 
replicates) One-way ANOVA followed by Tukey’s multiple comparisons test shows 
significant difference (p < 0.05 for all comparisons) in blue light treatment survival 
between R. microsporus and M. circinelloides and other species tested. B) 
Representative images of fungal growth on agar plates following blue light treatment 
and 7-10 days of growth at room temperature. 
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Germination is permanently blocked in most fungal species, but only delayed in 
Mucormycetes and Candida. 
 To visualize blue light effects on fungal pathogens we performed time-lapse 
imaging on treated fungal spores and additionally included Candida albicans, which 
has previously been shown to be sensitive to blue light killing (Zhang, et al., 2014) 
(Figure 3.2). Time lapse imaging demonstrated that blue light treatment permanently 
inhibited germination of Scedosporium, Lomentospora and Fusarium species, but that 
Rhizopus microsporus and Candida albicans SN152 eventually recovered full growth 
capability.  Thus, blue light induces a germination/growth arrest that appears 
permanent in some fungi, but only transient in the Mucormycetes and some Candida 
species.   
 Interestingly, during these studies we also made the chance observation of R. 
microsporus changing its morphology during germination into yeast-like cells that are 
capable of division by budding (Figure 3.2). Further analysis demonstrated that 
budding is suppressed by exposure to light (Figure 3.3). Budding-like of this sort has 
been previously reported for M. circinelloides (Omoifo, 2013) but never previously 
observed in Rhizopus species, so this observation raises the possibility that budding-
like may be widespread within the Mucormycetes. 
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Figure 3.2 Visualization of blue light effect on fungal spores and cells. 
Time-lapse imaging shows that blue light 60 min treatment (216 J/cm2) under 
controlled temperature conditions is effective against Scedosporium and Fusarium 
species but not C. albicans or Mucormycetes. 
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Figure 3.3 Mucormycetes switch their morphology to budding-like yeast in the 
absence of light exposure. 
Both R. microsporus and M. circinelloides NRRL 3631 were washed off the plates and 
inoculated in sabouraud broth for 10 hours. One sample was exposed to light while the 
second covered with aluminum foil. Both strains switch their morphology from 
filamentation to a yeast-like budding when deprived of light during germination-
conducive conditions. 
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Blue light exposure leads to secondary heating, but this is not a major 
contributor to the growth inhibition effect. 
 During our investigations we noted that treated samples were significantly 
warmer than untreated controls.  We therefore measured temperature within the 
medium for samples within the blue light instrument that were either exposed to blue 
light or wrapped within foil.  In both cases, we noted a very rapid increase in 
temperature during instrument operation (Figure 3.4).  Such temperatures are likely to 
be deleterious to fungal spore survival and we therefore repeated our blue light 
treatment experiments by housing the instrument within a cold room, which limited the 
maximum temperature experienced to 37° C (Figure 3.5), a temperature that is fully 
permissive for growth of these pathogens.  When we repeated this assay under these 
conditions, blue light retained its potent inhibitory effect on the Fusarium and 
Scedosporium, Lomentospora species and, as before, showed no inhibition of 
Mucormycete survival (Figure 3.5).  
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(This graph has been produced by Helen Wrigley, 2016). 
Figure 3.4 Temperature rises rapidly inside the blue light instrument during 
operation. 
Incubating samples on ice within the instrument is insufficient to reduce this effect, but 
housing the instrument within a cold room (at 4° C) during treatment maintains sample 
temperatures at 37° C. 
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(C. albicans data has been produced by Helen Wrigley, 2016). 
Figure 3.5 60 min blue light treatment of fungal spores in cold room conditions 
shows similar growth inhibition effects. 
Spores were inoculated in PBS and treated with blue light before plating for growth 
and CFU enumeration. Error bars represent standard deviation (n=3, with three 
biological replicates) One-way ANOVA followed by Tukey’s multiple comparisons test 
shows significant difference (p < 0.05 for all comparisons) in blue light treatment 
survival between R. microsporus and M. circinelloides and other species tested. 
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Blue light is highly effective against pre-germinated spores. 
 In clinical settings, fungal infections might have germinated and begun hyphal 
growth before treatment can be applied. Therefore, we investigated the effect of blue 
light treatment on pre-germinated spores. Spores were first germinated for 5 hours, 
and then exposed to 60 minutes of blue light (in cold room conditions to limit 
temperature exposure to below 37° C) followed by time-lapse microscopy (Figure 3.6). 
In all cases, blue light treatment effectively stopped further growth of germ tubes, 
including Mucormycete species (which show resistance to blue light as spores, Figure 
3.1). Thus, blue light is an effective inhibitory treatment for fungal spores that have 
already pre-germinated, including for species that are resistant to such treatment as 
spores. 
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Figure 3.6 60 min blue light treatment show antifungal activity on pre-germinated 
spores.  
Time-lapse imaging shows inhibition of further fungal growth after blue light treatment. 
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3.4 Discussion 
 Here we have tested the trauma-associated fungi, including Mucormycetes, 
Scedosporium, Lomentospora, Fusarium and Candida spp. against blue light therapy. 
 Fungal tissue infections are very difficult to treat as many of these species show 
intrinsic resistance to antifungals and drug accessibility to wounded tissue is poor. 
Thus, blue light may represent a novel approach for dealing with such infections.  
 We have demonstrated that 60 minutes of blue light treatment, providing an 
equivalent total dosage of 216 J/cm2, shows potent inhibition of fungal growth for 
spores that have already germinated and produced hyphae in all species tested. In 
addition, such an approach can also be an effective decontaminant of un-germinated 
spores for most, but not all, pathogenic species. However, this approach has two notes 
of caution. Firstly, blue light did not kill the highly antifungal resistant Mucormycete 
species tested, but rather enhanced subsequent germination. In addition, the lack of 
white light inherent in this device leads species, R. microsporus and M. circinelloides, 
to switch morphology, the immunological consequences of which are not known. 
 Further investigation of interactions between innate immune phagocytes, such 
as macrophages and neutrophils (first line of defence for fungal pathogens) with the 
fungal spores that had undergone the morphological switch would help us to gain 
knowledge about potential virulence and pathogen survival within host. This likely 
reflects the previously characterized role of blue wavelengths as a regulator of fungal 
growth (Idnurm & Heitman, 2005).  Light that regulates asexual and sexual 
reproduction as well as pigment formation and direction of growth is a very important 
aspect of fungal survival within the environment, adaptation and dissemination (Idnurm 
& Heitman, 2005).   
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 Secondly, we note that the high-intensity blue light system used in our work and 
by others (Halstead et al., 2016) generates considerable heat. This factor is important 
to control for when assessing its efficacy against pathogenic microbes on wounded 
skin.  Thus, blue light offers a potentially powerful antimicrobial approach, but its 
application in situations where infections with Mucormycetes and some Candida 
species are likely should be undertaken with caution.     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  93 
4. SCEDOSPORIUM AND LOMENTOSPORA INTERACTIONS WITH THE HOST 
INNATE IMMUNE SYSTEM 
 
Research Aim 
Understand the basic interaction of S. apiospermum and L. prolificans with 
macrophages. 
 
4.1 Introduction 
 The Scedosporium and Lomentospora (previously grouped together as 
Scedosporium) genera consist of two medically important species, Scedosporium 
apiospermum/Pseudallescheria boydii (sexual state of S. apiospermum) and 
Lomentospora prolificans (formerly called Scedosporium prolificans) (Cortez et al., 
2008). S. prolificans was renamed L. prolificans due to its phylogenic distance from 
other Scedosporium spp. (Luo et al., 2017). These omnipresent filamentous fungi are 
found in sewage, polluted water and soil, are able to grow in aerobic as well as 
anaerobic conditions (i.e. a facultative anaerobe; an organism able to make ATP in the 
presence of oxygen, but capable of switching to anaerobic respiration when oxygen is 
absent), tolerating 5 % or more salt and/or magnesium chloride and surviving in 
temperatures as high as 42° C (Guarro et al., 2006).  
 Spores, the infectious agent, can cause infection of different body parts. The 
most frequent infections are subcutaneous (Tóth et al., 2017; Vijaya. D et al., 2013; 
Goldman et al., 2016; Bhagavatula et al., 2014), but systemic infections can also occur 
following organ transplantation, such as kidney (Rathi et al., 2014), lung (Balandin et 
al., 2016) or heart (Clement et al., 2015) transplantations. Cystic fibrosis (CF) is also 
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commonly associated with Scedosporium/Lomentospora infections (Schwarz et al., 
2017; Hirschi et al., 2012) as well as leukemia (Elsayed et al., 1999). However other 
invasive organ infections without underlying diseases also occur with these species, 
such as heart (Kelly et al., 2016), lungs (Holmes et al., 2013; Masukane et al., 2017), 
nasal (Kishimoto et al., 2017; Alvarez et al., 1995; Patel and Orlandi, 2015), contact 
lens (Arthur et al., 2001) and near-drowning associated infections (He et al., 2015). 
 The work of several groups has demonstrated species-specific susceptibility to 
antifungals within the S. apiospermum/P. boydii species complex (Cooley et al., 2007; 
Lackner et al., 2012; Lackner et al., 2014; Wongsuk et al., 2017).  Despite their 
previous taxonomic similarity, there are huge differences such as distinct clinical 
features depending on the host immune function and species isolated between the S. 
apiospermum/P. boydii species complex and L. prolificans (Cooley et al., 2007). In 
addition to these inter-species differences, there is also considerable variation in 
antifungal resistance between clinical and environmental strains (Lackner et al., 2012; 
Lackner et al., 2014). The only antifungal effective against Scedosporium spp. is 
voriconazole (Alastruey-Izquierdo et al., 2007; Wang et al., 2015; Zeng et al., 2004; 
Gil-Lamaignere et al., 2002). However, L. prolificans has been shown to be highly 
resistant to many antifungals (Meletiadis, J. et al., 2000; Pellon et al., 2017; Pellon, A. 
et al., 2018). The intrinsic antifungal resistance of the Scedosporium/Lomentospora 
complex has driven an investigation of alternative treatments such as: N-Chlorotaurine, 
a long-lived oxidant produced by activated monocytes and granulocytes (Lackner et 
al., 2015); a monoclonal antibody targeting fungal glycosphingolipids in combination 
with voriconazole (Rollin-Pinheiro et al., 2014); a combination of posaconazole and 
itraconazole with calcineurin inhibitor tacrolimus (TCR) and/or the Hsp90 inhibitor 17-
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demethoxy-17-(2-propenylamino) geldanamycin (17AAG) that induced apoptosis of L. 
prolificans (Shirazi and Kontoyiannis, 2014); or different application therapy such as 
combination therapy of terbinafine and itraconazole (Meletiadis et al., 2000). In 
addition, novel treatments such as echinocandins with granulocyte macrophage 
colony-stimuling factor (GM-CSF) (Goldman et al., 2016) or treatment of L. prolificans 
by incorporating voriconazole-loaded cement and spacer into hip replacements 
(Daniele et al., 2017) have been attempted with varying success.  
 To aid future development of antifungals against the Scedosporium/ 
Pseudallescheria and Lomentospora species complex, there is a need to understand 
how those fungi interact with the host immune system. The innate immune system is 
the first line of defense against potentially fatal fungal infections. Patrolling phagocytes, 
such as macrophages and neutrophils, ingest invading fungi through recognition of 
surface structures that comprise the fungal cell wall. Once ingested, the harsh 
environment of the phagosome is thought to kill and eradicate the pathogen. Few 
research groups have been investigating interaction of Scedosporium and 
Lomentospora spp. with innate immune cells and the interaction of these pathogens 
with the host it is still very understudied.  
 One of first phagocytic cells to encounter Scedosporium are macrophages, 
which engulf spores to prevent spore germination (Gil-Lamaignere et al., 2003). Gil-
Lamaignere et al. (2002) tested antifungal activities of voriconazole (VRC), 
intraconazole (ITC) and posaconazole (PSC) in mixtures with human 
polymorphonuclear leukocytes (PMNs). They showed that PMNs, when combined with 
antifungals, were able to cause more damage to the hyphae of S. apiospermum and 
S. prolificans. (Gil-Lamaignere et al., 2002). Xisto et al. (2015), have shown that 
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peptidorhamnomannan (PRM) present at the cell wall of S. prolificans, could be 
involved in fungal survival in the host; something that appears to be dependent on the 
O-linked oligosaccharides within the molecule (Xisto et al., 2015). They showed that 
adding PRM to macrophages led to dose-dependent inhibition of phagocytosis of 
spores (Xisto et al., 2015). Moreover, killing of fungal spores was unaffected and PRM 
triggered TNF-alpha release by macrophages.  
 Some research groups have been investigating the influence of pH, 
temperature, CO2 tension (Mello et al., 2016) on germination of 
Scedosporium/Lomentospora or cell wall changes during spore maturation (Ghamrawi 
et al., 2014) which add a relevant information about biological processes that can be 
directly related to antifungal resistance and virulence factors. 
 Pellon et al. (2018) investigated microglial cells (resident immune cells in CNS 
(Central Nervous System)) interaction with L. prolificans.  They showed reduced 
phagocytosis, the increase of oxidative burst, and the production of pro-inflammatory 
response in comparison to macrophages such as the murine macrophage cell line 
J774A.1 or murine BMDM (Bone Marrow Derived Macrophages). Moreover, microglial 
phagocytosis of L. prolificans was also dectin-1 and mannose receptor dependent 
(Pellon et al., 2018). These findings are very interesting as the pattern recognition 
receptors (PRRs) involved in recognition of L. prolificans are very understudied and 
still remain an important biological question. 
 Here we investigated how host environment and innate immune cells such as 
murine macrophages, human monocyte-derived macrophages and iPSC-derived 
macrophages response to Scedosporium/Lomentospora spp. This research will help 
us to understand how those highly antifungal resistant human pathogens interact and 
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manipulate the immune system and help us to gain the knowledge of further 
developing novel drugs to boost the immune system to fight those fungal species.  
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4.2 Materials and Methods 
Unless otherwise stated all reagents were purchased from Sigma Aldrich UK. 
 Strains, growth conditions and opsonisation. Strains used in experiments: 
Scedosporium apiospermum IHEM 14462, Scedosporium apiospermum IHEM 7656, 
Scedosporium apiospermum IHEM 13945 and Lomentospora prolificans IHEM 5608, 
Lomentospora prolificans IHEM 19020, Lomentospora prolificans IHEM 18755; 
Lomentospora prolificans albino (no melanin) mutant to WT 3.1 strain of Lomentospora 
prolificans ΔLppks::hph (Al-Laaeiby, A. et al., 2016) kindly supplied by Prof. 
Christopher Thornton, University of Exeter) and Cryptococcus neoformans KN99 alpha 
(Upadhya, R. et al. 2017)., and Cryptococcus neoformans KN99GFP (Garelnabi et al., 
2018). All Scedosporium and Lomentospora strains were grown on Potato Glucose 
agar plates for at least 10 days before use at room temperature. Cryptococcus spp. 
were grown on YPD agar plates for 2 days at 25° C, then grown overnight in YPD broth 
before use at 20 rpm at 25° C. For microscopy experiments, the spore pellet (spores 
harvested from agar plates by PBS, spun down 1000 x g, 3 min, maximum breaking 
and acceleration, then resuspended in PBS) of Scedosporium and Lomentospora spp. 
was resuspended in serum free DMEM and opsonised, or not, with 10% live Human 
AB Serum in DMEM or RMPI, depending on the tissue culture cells used, for 1 hour, 
rotating at room temperature. C. neoformans KN99 GFP was inoculated in YPD broth 
overnight at 25° C, rotating. The following day, cell number was counted, diluted to 1 
x 107/ ml cell concentration and opsonised with 10 % Human AB Serum for 1 hour, 
rotating in room temperature. 
 Macrophage cell line culture. Murine macrophage-like cell line (J774A. 1) was 
maintained in DMEM media supplemented with 100 U/ml of Penicillin and 100 U/ml of 
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Streptomycin, 2 mM of L-glutamine and 10% Fetal Bovine Serum (FBS) in a humidified 
environment at 37° C with 5 % CO2, and used between 5 and 15 passages from the 
time of thawing. On the day of infection, macrophage media was replaced with serum 
free DMEM (DMEM as before but without FBS serum) one hour before infection.  
 HMDMs isolation and differentiation. Two densities of Percoll were made. 
1.079 density [percoll- 19.708 ml, 11.792 ml of distilled water, 3.5 ml of 1.5 M of NaCl]. 
1.098 density: [percoll- 24.823 ml, 6.677 ml of distilled water, 3.5 ml of 1.5 M of NaCl]. 
6 ml of 1.079 density percoll was layered in the tubes (Thermo-Fisher Scientific), then 
6 ml of 1.098 density percoll was layered under 1.079 density percoll. 6 ml of whole 
blood from healthy volunteers was collected into blood vacutainers containing 
anticoagulant, then layered over percoll and spun down at 150 x g/8min/no braking, 
followed by 1200 x g/12 min/no braking. The monocyte/lymphocyte layer and the 
neutrophil layer was removed and topped up with RBC lysis buffer in 1/3 ratio (1 l 
distilled water, 8.3 g/l NH4Cl, 1 g/l KHCO3, 0.04 g/l Na2EDTA 2 H2O and 2.5 g/l BSA 
(Bovine Serum Albumin, filter sterilized)), gently inverted for 3 minutes and spun down 
for 6 min/ at 400 x g/ maximum braking. Cells were then washed twice with (ice cold 
for monocytes) and (room temperature for neutrophils) PBS. Monocytes were then 
resuspended in RPMI 1640 with L-Glutamine (Gibco) with 5 % human AB serum, heat 
inactivated (56 degrees for 30 min) supplemented with 100 U/ml of Penicillin- 
Streptomycin solution for counting. Then cells were seeded at 0.5 x106 cells/well in a 
48 well plate (Grainer) and incubated at 37° C, 5 % CO2 for 1 h to allow cells to attach 
to the surface. Following that, differentiation media (RPMI 1640 with L-Glutamine 
(Gibco) with 5 % human AB serum, heat inactivated supplemented with 100 U/ml of 
Penicillin- Streptomycin solution + M-CSF 20 ng/ml was incubated for 7-15 days in 37° 
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C, 5 % CO2 with media change every 3 days. Neutrophils were resuspended in 
RPMI 1640 with L-Glutamine (Gibco) supplemented with 100 U/ml of Penicillin- 
Streptomycin solution and infected straight away.  
 Induced Pluripotent Stem cells (iPSCs). All steps until macrophages were 
derived from iPSCs, were done by Dr. Leanne Taylor-Smith, University of Birmingham. 
iPSCs were maintained in plates with Matrigel and MTeSR1 (Stemcell Technologies). 
On day 0, cells were seeded into an AggreWell 800 plate (Stemcell Technologies) in 
mTeSR1 (Stemcell Technologies) medium with 10µM ROCKi (AbCam Biochemicals) 
in EB media to each well. Following seeding, the AggreWell plate was centrifuged at 
100x g for 3 minutes for even distribution of cells in microwells. Cells were incubated 
in a humidified 37o C, 5 % CO2 incubator. On days 1-3, mesoderm embryoid bodies 
were fed (media changed) with EB media (mTeSR (Stemcell Technologies), BMP4 at 
50 ng/ml (Invitrogen), VEGF at 50 ng/ml (PeproTech), SCF at 20 ng/ml (Miltenyi). EBs 
were then harvested out of the aggrewells (by taking up the well contents and 
transferring to 40 µm cell strainer inverted over a 50 ml centrifuge tube. Cells were 
washed on the strainer several times with PBS, then the sieve was moved into fresh 
50 ml tube and EBs washed off with EB media). EBs were then moved into T75 tissue 
culture flasks (monocyte factory) and returned to incubator. Monocyte factories were 
fed weekly with 50 % removal and replacement of factory medium (500 ml XVIVO15 
(Lonza), 5 ml/ 500 ml GlutaMax (Gibco), 5 ml/ 500 ml P/S (Gibco), 500 ul/ 500 ml 2-
Mercaptoethanol (Gibco), M-CSF at 100 ng/ml (Invitrogen), IL-3 at 25 ng/ml 
(Invitrogen). Monocytes were harvested from the factory flasks (by collection of 
supernatant). Monocytes were then seeded at 1 x 107/ml density in 48 well plates and 
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differentiated into macrophages using medium: 50 ml XVIVO15, 0.5 ml/ 50 ml 
GlutaMax, 0.5 ml/50 ml P/S, M-CSF at 100 ng/ml for 7-14 days. 
 Infection of macrophages. The murine macrophage cell line (J774A.1) were 
seeded in to 24 well plates (Greiner) at a concentration of 1 x 105 cells/ ml, 24 hours 
before the experiment, in cDMEM media. On the day of experimentation, for all 
macrophages media was replaced with serum free DMEM (J774s) or Serum free RPMI 
(iPSC derived macrophages) one hour before infection. Positive spore colonies of 
Scedosporium and Lomentospora spp. were harvested from 2-week-old potato 
glucose agar cultures using PBS and spun down at 1000x g/ 3min/ maximum braking. 
The spore pellet was resuspended in serum free RPMI 1640 (or DMEM for J774A.1) 
with L-Glutamine (Gibco) supplemented with 100 U/ml of Penicillin- Streptomycin 
solution. C. neoformans KN99 GFP mCherry was inoculated in YPD broth over night 
in 25° C, rotating 20 rpm. Before use, spores were counted and opsonised with 10 % 
Human AB Serum for 1 hour, rotating at room temperature. Cryptococcus cells, 
Scedosporium and Lomentospora spores were added to the macrophages in 1:10 and 
1:5 infection ratio respectively. Cryptococcus cells were added 2 hours before infection 
with Scedosporium and Lomentospora and washed with PBS three times.  
 For phagosome acidification experiments, at the time of infection, 50 nM of 
LysoTracker Red DND-99 (Thermo Fisher) in serum free DMEM was added per well.  
 For some of the experiments, Scedosporium and Lomentospora spp. were 
either heat killed (30 min, 80° C) or 4 % paraformaldehyde (PFA) (VWR) fixed (20 min 
in room temperature) and then washed in PBS before opsonisation and infection.  
 XMD17-109 treatment with 1 μM for duration of 18 hours as added at the time 
of infection with Cryptococcus ((a specific inhibitor of ERK5, a kinase implicated in the 
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regulation of vomocytosis (Gilbert et al., 2017)) and co-infection with C. neoformans 
KN99 were also used for some of the experiments. 
 To assess Scedosporium and Lomentospora spp. survival following 
phagocytosis, after 2 hours infection cells were washed 3 times with serum free 
DMEM. Murine macrophages were lysed with distilled water for 20 min in room 
temperature and samples were plated (after serial dilution) on potato glucose agar 
plates for CFU count. As a control, spores were also plated without phagocytosis. 
Colonies were counted once they were large enough to be clearly observed.  
 Time-lapse imaging was performed on infected macrophages using a Nikon 
Eclipse Ti microscope with ELWD Ph1 0.52 20x objective for 18 hours with 5 min frame 
intervals. Camera, QICam (QImaging), environmental chamber with 37° C, 5 % CO2. 
Movies were analysed using NIS Elements software. 
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4.3 Results 
Scedosporium and Lomentospora spp. are well phagocytosed by macrophages.  
 Spores of Scedosporium and Lomentospora spp. are infectious agents causing 
infections in both immunocompetent and immunocompromised individuals, resulting in 
high morbidity and mortality. Innate immune cells are the first line of defense against 
fungal invasion. We exposed J774A.1 macrophages to non-opsonised spores then 
counted internalisation. Both species, live and heat-killed, of different isolates of S. 
apiospermum and L. prolificans are well phagocytosed, with the majority of uptake 
occurring within the first 2 hours of infection (Figure 4.1-4.3). Therefore, for further 
experiments we chose 2 hours infection time to allow for sufficient phagocytosis.  
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Figure 4.1 Time and number of live spores phagocytosed by murine cell line 
J774A.1. 
The majority of live spores of all isolates of Scedosporium and Lomentospora spp. 
were phagocytosed by macrophages within the first 120 minutes. Time-lapse imaging 
was performed on J774A.1 murine cell line infected with fungal spores using a Nikon 
Eclipse Ti microscope with LWD 0.52 20x objective for 18 hours.  Movies were 
analysed and phagocytosis scored using NIS Elements software. Error bars represent 
standard deviation (n=3). Statistical analysis was conducted using two-way ANOVA 
with Dunnett’s multiple comparison test, where all times where compared to first 60 
min of phagocytosis. *p < 0.05, **p < 0.01, ***p < 0.001. 
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Figure 4.2 Time and number of heat-killed spores phagocytosed by murine cell 
line J774A.1. 
The majority of heat-killed spores of all isolates of Scedosporium and Lomentospora 
spp. were phagocytosed by macrophages within first 120 minutes. Time-lapse imaging 
was performed on J774A.1 murine cell line infected with fungal spores using a Nikon 
Eclipse Ti microscope with LWD 0.52 20x objective for 18 hours. Spores were heat 
killed at 80° C for 60 min prior macrophage infection. Movies were analysed and 
phagocytosis was scored using NIS Elements software. Error bars represent standard 
deviation (n=3) statistical analysis was conducted using two-way ANOVA with 
Dunnett’s multiple comparison test, where all times where compared to first 60 min of 
phagocytosis. *p < 0.05, **p < 0.01, ***p < 0.001. 
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Figure 4.3 Phagocytic rate at 2 hours infection. 
Time-lapse imaging was performed on J774A.1 murine cell line infected with fungal 
spores using a Nikon Eclipse Ti microscope with LWD 0.52 20x objective for 18 hours. 
Spores were heat killed at 80° C for 60 min prior macrophage infection. Movies were 
analysed and phagocytosis was scored using NIS Elements software. Error bars 
represent standard deviation (n=3) statistical analysis was conducted using two-way 
ANOVA with Dunnett’s multiple comparison test, where all times where compared to 
first 60 min of phagocytosis. *p < 0.05, **p < 0.01, ***p < 0.001. 
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The murine macrophage cell line is not able to inhibit spore germination. 
 The innate immune system is the first line of defense against potentially fatal 
fungal infections. Patrolling phagocytes recognise fungus via their cell wall structure 
and then ingest and attempt to kill the microbe. However, very little is known of the 
host defense against Scedosporium and Lomentospora spp. The primary role of the 
phagocytic cell is to inhibit spore germination. Therefore, we first investigated whether 
J774A.1 macrophages are able to inhibit fungal germination following phagocytosis. 
We exposed J774A.1 macrophages to different isolates of both species and scored 
germination over an 18 hour time-lapse movie. Germination of Scedosporium and 
Lomentospora spp. after phagocytosis by the murine macrophage cell line J774A.1 is 
very high (up to 80 %), especially for L. prolificans isolates. We found a significant 
difference in spore germination between S. apiospermum 14462 and L. prolificans 
5608 isolates (Figure 4.4), with L. prolificans germinating more frequently than S. 
apiospermum within macrophages, therefore we decided to use those two isolates for 
further experiments.  
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Figure 4.4 Strain and species variation in intracellular germination within 
J774.A1 macrophages. 
Time-lapse imaging was performed and movies were analysed for germination 
percentage (%) of phagocytosed spores within J774 cells. Error bars represent 
standard deviation (n=3). Statistical analysis was conducted using two-way ANOVA 
with Tukey’s multiple comparison test. *p < 0.05, **p < 0.01, ***p < 0.001.  
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The murine macrophage cell line fails to mature the phagosome. 
 Following successful phagocytosis, macrophages attempt to destroy and 
eradicate internalised pathogens. To do that, the phagosome undergoes multiple 
fusion and fission events to generate a toxic environment to destroy pathogens. One 
of those conditions is increased phagosome acidification, which also serves as a 
marker of phagosome maturation. After observing that some spores are able to 
germinate inside J774A.1 cells, we wanted to see if this was because they were able 
to manipulate phagosome acidification. To test whether phagosomal maturation 
proceeds normally with these species, we monitored spores that had been internalised 
by J774A.1 macrophages via time-lapse microscopy. We investigated phagosome 
acidification by adding 50 nM of LysoTracker Red DND-99 at the time of infection 
(J774A.1 macrophages exposed to S. apiospermum and L. prolificans isolates) by 
either live or heat-killed spores of both strains and scored for acidification over 18 hours 
of time-lapse microscopy (LysoTracker Red dye selectively accumulates in cellular 
compartments with low internal pH). There is a noticeable difference (around 60-80 %) 
between phagosome maturation when macrophages were infected with heat-killed in 
comparison to live spores (Figure 4.5). These results suggest that both S. 
apiospermum and L. prolificans spp. are able to survive within macrophage 
phagosomes and avoid phagosome acidification enabling them to germinate, 
penetrate and finally kill host cells. There is no significant difference between live 
spores and Scedosporium and Lomentospora spp., however there is significant 
difference of phagosome acidification between heat killed spores of L. prolificans and 
other strains. 
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Figure 4.5 Phagosome acidification of murine macrophage cell line J774A.1 
followed by Scedosporium and Lomentospora spp. phagocytosis. 
The J774A.1 murine cell line was infected with fungal spores of Scedosporium and 
Lomentospora spp. and time-lapse imaging was performed using Lysotracker Red (50 
nM/ ml) to identify phagosome acidification with internalized spores. Movies were 
analysed and acidification was scored using NIS Elements software. Error bars 
represent standard deviation (n=3) statistical analysis was conducted using two-way 
ANOVA with Tukey’s multiple comparison test. *p < 0.05, **p < 0.01, ***p < 0.00. There 
was no significant difference between strains. 
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S. apiospermum and L. prolificans spp. readily undergo lateral transfer, but do 
not exhibit vomocytosis, and are able to survive and germinate within 
macrophages despite serum opsonisation. 
 It is known that for optimal phagocytosis, the presence of antibodies and 
complement components are required on the pathogen surface. It has been shown 
previously that serum opsonisation stimulates immune system and increase hyphae 
damage of filamentous fungi (Posch et al., 2017). Opsonisation of Aspergillus and 
Cryptococcus enhances phagocytosis, similarly to Candida, whose phagocytosis and 
killing is also enhanced by opsonisation (Shoham and Levitz, 2005). Therefore, we 
have investigated whether human AB serum opsonisation of S. apiospermum and L. 
prolificans spp. spores has any effect on germination within J774A.1 macrophages in 
comparison to unopsonised control (Figure 4.6 A); as well as the fungus survival within 
the murine macrophages followed by 2 hours infection (Figure 4.6 B). We found no 
significant difference between spores that has been opsonised and unopsonised in 
terms of germination and we confirmed these results by lysing infected cells and plating 
spores for CFU count (Figure 4.6 B). These results might suggest that complement 
receptors may not be involved in Scedosporium/Lomentospora spp.  phagocytosis nor 
survival within macrophages. Although, more studies in this direction would have to be 
done to make a clear statement.  
 It is also known that some fungal pathogens are able to escape from host 
phagocytes by two processes, non-lytic expulsion (vomocytosis) and cell-cell transfer 
(lateral transfer). Therefore, we investigated whether S. apiospermum and L. 
prolificans spp. are able to vomocytose and/or undergo lateral transfer, and if human 
AB serum opsonisation makes any difference to those events in comparison to 
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unopsonised fungal spores (Figure 4.5 C). Intriguingly, both Scedosporium and 
Lomentospora spp. were able to lateral transfer but not undergo vomocytosis (Figure 
4.5 C), making these the first intracellular pathogenic fungi known not to be 
vomocytosed.  
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Figure 4.6 Scedosporium and Lomentospora spp. exhibit lateral transfer, but do 
not vomocytose, and survive within the host despite serum opsonisation. 
J774A.1 murine cell line was infected with fungal spores of Scedosporium and 
Lomentospora spp. and time-lapse imaging was performed using a Nikon Eclipse Ti 
microscope with LWD 0.52 20x objective for 18 hours (A and C). Spore pellet was 
resuspended in serum free DMEM and some were opsonised with Human AB Serum 
prior infection of murine macrophage cell line J774A.1. Followed 2 hours infection, 
macrophages were lysed and spores were plated on potato glucose agar plates for 
CFU count. As a control, spores were also plated without phagocytosis. Agar plates 
were counted few days later (B).  
Movies were analysed and germination, lateral transfer and vomocytosis events 
percentage (%) was scored using NIS Elements software. Error bars represent 
standard deviation (n=3). Statistical analysis was conducted using one-way ANOVA 
with Tukey’s multiple comparison test. *p < 0.05, **p < 0.01, ***p < 0.001 for graph (A, 
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B), and two-way ANOVA with Sidak’s multiple comparison test. *p < 0.05, **p < 0.01, 
***p < 0.001 for graph (C). 
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Scedosporium and Lomentospora spp. exhibit ability to lateral transfer but do 
not vomocytose despite different conditions tested. 
 Following our observation of S. apiospermum and L. prolificans ability of lateral 
transfer and lack of vomocytosis we decided to test whether vomocytosis of 
Scedosporium/Lomentospora spp. could be triggered either by XMD17.109, an 
inhibitor of the kinase ERK5 that has previously been shown to induce vomocytosis) 
or by co-infection with C. neoformans KN99. Our results indicate that Scedosporium 
and Lomentospora spp. remained unable to vomocytose in either situation (Figure 4.7 
A) in the coinfection assays, although individual macrophages were able to 
vomocytose Cryptococci, co-infecting Scedosporium or Lomentospora spores were 
not expelled (Figure 4.7 A).  In both cases, lateral transfer was unaffected (Figure 4.7 
B).   
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Figure 4.7 Scedosporium and Lomentospora spp. exhibit ability to lateral 
transfer but do not vomocytose despite different conditions tested. 
The J774A.1 murine cell line was infected with fungal spores of Scedosporium and 
Lomentospora spp. and time-lapse imaging was performed using a Nikon Eclipse Ti 
microscope with LWD 0.52 20x objective for 18 hours. Movies were analysed and 
vomocytosis (A) and lateral transfer (B) events were scored using NIS Elements 
software. Error bars represent standard deviation (n=3). Statistical analysis was 
conducted using two-way ANOVA with Tukey’s multiple comparison test. *p < 0.05, **p 
< 0.01, ***p < 0.001.  
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S. apiospermum and L. prolificans lateral transfer and lack of vomocytosis is 
conserved across different host cells. 
 To test whether the remarkable behavior of S. apiospermum and L. prolificans 
is reproducible in macrophages from different backgrounds, we infected primary cells, 
Human Monocyte Derived- Macrophages (HMDMs) and iPSC-derived macrophages 
(Stem cells derived macrophages) cell line, and again scored for vomocytosis and 
lateral transfer. Our results indicate that lateral transfer and vomocytosis and 
germination pattern is conserved across different cell types tested (Figure 4.8-4.11). 
Those results for the first time present Scedosporium and Lomentospora spp. to be 
one of very few fungal pathogens that are not being able to undergoes vomocytosis 
and indicates that lateral transfer and vomocytosis are two separate events. We have 
also tested here, two strains kindly provided by Prof. Christopher Thornton (University 
of Exeter) such as Lomentospora prolificans albino (no melanin) mutant to WT 3.1 
strain of Lomentospora prolificans ΔLppks::hph. Al-Laaeiby et al. (2016) investigated 
how melanin of L. prolificans protects the fungus from H2O2 oxidative stress, UV and 
amphotericin B. They showed that melanin deficient strains are more susceptible to 
H2O2 oxidative stress and UV killing but not to amp B (Al-Laaeiby et al., 2016). 
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Figure 4.8 Germination of Scedosporium and Lomentospora spp. within 
macrophages remain conserved across different immune cell sources. 
Murine macrophages cell line J774A.1, human monocyte derived macrophages 
(HMDM) and iPSC-derived macrophages were infected with Scedosporium, 
Lomentospora and Cryptococcus spp. and time-lapse imaging was performed using a 
Nikon Eclipse Ti microscope with LWD 0.52 20x objective for 18 hours. Movies were 
analysed and germination percentage (%) was scored using NIS Elements software. 
Error bars represent standard deviation (n=3). Statistical analysis was conducted using 
two-way ANOVA with Tukey’s multiple comparison test. *p < 0.05, **p < 0.01, ***p < 
0.001. We did not test L. prolificans WT 3.1 and Lppks::hph in infection with J774A.1 
murine macrophages. 
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Figure 4.9 Lateral transfer was only noticed for Scedosporium and 
Lomentospora spp. but not for Cryptococcus neoformans across different 
immune cell sources. 
The murine macrophage cell line J774A.1, human monocyte derived macrophages 
(HMDM) and iPSC-derived macrophages were infected with Scedosporium, 
Lomentospora and Cryptococcus spp. and time-lapse imaging was performed using a 
Nikon Eclipse Ti microscope with LWD 0.52 20x objective for 18 hours. Movies were 
analysed and lateral transfer percentage (%) was scored using NIS Elements software. 
Error bars represent standard deviation (n=3). Statistical analysis was conducted using 
two-way ANOVA with Tukey’s multiple comparison test. *p < 0.05, **p < 0.01, ***p < 
0.001.  
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Figure 4.10 Vomocytosis was only recorded for Cryptococcus neoformans but 
not for Scedosporium and Lomentospora spp. across different cell sources. 
Murine macrophages cell line J774A.1, human monocyte derived macrophages 
(HMDM) and iPSC-derived macrophages were infected with Scedosporium, 
Lomentospora and Cryptococcus spp. and time-lapse imaging was performed using a 
Nikon Eclipse Ti microscope with LWD 0.52 20x objective for 18 hours. Movies were 
analysed and vomocytosis percentage (%) was scored using NIS Elements software. 
Error bars represent standard deviation (n=3). Statistical analysis was conducted using 
two-way ANOVA with Tukey’s multiple comparison test. *p < 0.05, **p < 0.01, ***p < 
0.001. Percentage vomocytosis is the percentage of infected macrophages that has 
experiences at least one vomocytosis event.  
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Figure 4.11 Visualisation of different behaviours of spores/cells of L. prolificans 
and C. neoformans KN99 (mCherry) within iPSC-derived macrophages. 
iPSC-derived macrophages were infected with Lomentospora and Cryptococcus spp. 
and time-lapse imaging was performed using a Nikon Eclipse Ti microscope with LWD 
0.52 20x objective for 18 hours. Movies were analysed using NIS Elements software. 
I) Different spore behaviours of L. prolificans within a single macrophage. One spore 
never germinates, while the other germinates and penetrates the macrophage. II) An 
event of lateral transfer of L. prolificans. III) C. neoformans undergo vomocytosis (in 
red) leaving the macrophage alive, but not for long since the same macrophage is 
infected with L. prolificans (in black) that germinates within macrophage and will soon 
penetrate and kill the cell.  
I 
III 
II 
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4.4 Discussion 
 Here we describe the interaction of Scedosporium and Lomentospora spp. with 
macrophages of the innate immune system, the first line defense for pathogenic fungi.  
 One of the first phagocytes approaching fungal pathogens are macrophages. 
They engulf and attempt to destroy and eradicate the pathogen. To do so, the 
macrophage phagosome undergoes maturation, and becomes acidified, highly 
oxidative and full of hydrolytic enzymes, which together kill the pathogen (Smith et al., 
2015). Despite this remarkable ability of phagocytes to eradicate microbes, many 
fungal pathogens are known to be able to avoid killing (for example by manipulation of 
phagosome acidification) and/or escape from the cell via vomocytosis or lateral 
transfer (Gilbert et al., 2017; Shah et al., 2016).  
 We have measured the percentage of spores germinated inside innate immune 
cells causing their penetration and death. Our data showed that different macrophages 
tested, such as murine macrophages cell line J774A.1, human monocyte derived 
macrophages (HMDM) and iPSC-derived macrophages are not able to inhibit spore 
germination followed by phagocytosis. S. apiospermum remain less virulent then L. 
prolificans in terms of macrophage penetration and killing. These results are similar to 
those presented by Roilides et al. (2009) who have shown that HMDM’s inhibited 
germination of L. prolificans less efficiently than A. fumigatus spores as a comparison. 
Al-Laaeiby et al. (2016) investigated how melanin of L. prolificans strain, protects the 
fungus from H2O2 oxidative stress, UV and amphotericin B. They showed that melanin 
deficient strains are more susceptible to H2O2 oxidative stress and UV killing but not to 
amp B (Al-Laaeiby et al., 2016). However, we showed that the melanin-deficient strains 
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(kindly provided by Prof. Christopher Thornton (University of Exeter)) remain virulent 
within macrophages and germinated, penetrating and killing them.  
 It is well known that coating fungal cell surfaces with complement proteins or 
opsonizing antibodies will enhance pathogen phagocytosis by macrophages (Erwig 
and Gow, 2016). However, we wanted to also investigate whether opsonisation of 
Scedosporium and Lomentospora spp. would have any effect on fungal survival within 
the murine macrophages cell line J774A.1. We found that there is no significant 
difference within opsonised and unopsonised spores in terms of fungus survival within 
the macrophage.  This may be due to the fact that complement receptors are not 
involved in phagocytosis/survival of Scedosporium and Lomentospora spp. within 
murine macrophages, although this remains to be tested.   
 Phagosome acidification plays a key role in pathogen killing. The low pH within 
the phagosomal lumen is achieved by proton pumping of V-ATPases (Flannagan et 
al., 2012). Microbial growth is restricted by the acidic environment but it also enhances 
proteolytic enzyme activation (Flannagan et al., 2012). Acidification is a marker of a 
mature phagosome, therefore we used LysoTracker Red probes to detect acidification 
of the phagosome following phagocytosis of Scedosporium and Lomentospora spp. 
We found that live spores of both strains are not efficiently killed due to very low 
phagosome acidification in comparison to heat-killed spores. These results suggest 
that the pathogen is able to manipulate host cells to avoid getting killed by acidification. 
It is known that some pathogens are able to manipulate the acidic environment and 
survive, for instance, Helicobacter pylori, which is able to produce ammonium from 
urea to buffer the phagosomal pH, to prevent maturation and allow for intraphagosomal 
survival (Flannagan et al., 2012). Similarly, Histoplasma capsulatum inhibits 
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accumulation of V-ATPase, however, how it does so remains unclear (Flannagan et 
al., 2012). Listeria monocytogenes express LLO, a pore-forming toxin, that prevents 
phagosome maturation and perturbation of luminal H+ and Ca2+ concentrations 
(Flannagan et al., 2012). However, the question of how Scedosporium and 
Lomentospora spp. remain viable within the phagosome due to the early study of those 
fungal spp. remains unanswered. 
 Another very interesting event is vomocytosis and/or lateral transfer. It is now 
known that some fungi are able to evade killing and escape from the phagocyte by two 
processes, non-lytic expulsion (vomocytosis) and cell-cell transfer (lateral transfer) (Ma 
et al., 2007; Gilbert et al., 2017; Ma et al., 2006; Shah et al., 2016). Therefore – we 
looked to see if these fungi are also able to do that. Our data using different fungal 
species suggest that vomocytosis and lateral transfer are two distinct processes. 
Scedosporium and Lomentospora spp. readily undergo lateral transfer, but are rarely 
vomocytosed, while the inverse was true for Cryptococcus spp. More interestingly, 
spores transferred to another macrophage were either killed or germinated inside the 
phagosome, leading to macrophage death.  These results put Scedosporium and 
Lomentospora spp. in a unique position of being one of very few fungal pathogens 
studied that do not perform vomocytosis. Interestingly, even treatment of macrophages 
with XMD17.109 did not encourage either of the species to vomocytose. This suggests 
that vomocytosis host cell escape by Scedosporium and Lomentospora spp. are being 
controlled by a different mechanism than vomocytosis in Cryptococcus. Also, those 
two fungal pathogens exhibit interesting behaviour in comparison to A. fumigatus that 
is known to be able to lateral transfer in HMDMs. Shah et al., (2016) has demonstrated 
that lateral transfer of A. fumigatus is calcineurin orchestrated. This mechanism is 
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thought to control fungal burden by programmed necrosis-dependent spore lateral 
transfer between macrophages and inhibition of spore germination. However, my 
observations suggests that lateral transfer of both Scedosporium and Lomentospora 
spp. are controlled by a different mechanism as they are not associated with 
macrophage necrosis (before lateral transfer) nor with inhibition of spore germination. 
Therefore, this important biological question remains unanswered at the moment and 
requires further investigation to be able to understand the importance of lateral transfer 
in patients’ outcome.  
 Taken together, Scedosporium and Lomentospora spp. behaviour within the 
innate immune cells observed in this study, such as prevention of phagosome 
acidification, ability to germinate within the macrophages, lateral transfer and lack of 
vomocytosis raise very important biological question of how these fungal species 
manipulate the host to survive and remain virulent. These unanswered biological 
questions may have an important impact on the medical condition of patients suffering 
from scedosporiosis and need to be investigated further. 
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5. DEVELOPING AN EX-VIVO SKIN MODEL AS A NOVEL APPROACH TO 
INVESTIGATE PATHOGENICITY OF FUNGAL SPORES 
 
Research Aim 
Investigate immune cells isolated from the ex-vivo skin interaction with fungal 
pathogens. 
 
5.1 Introduction 
 Skin, the biggest organ of the human body, is permanently exposed to the 
environment (Merad et al., 2008). Skin provides the first line of defense to all microbial 
pathogens, both those found in the environment as well as commensal organisms. By 
breaching this barrier, pathogens are able to get inside the body and cause life-
threatening infections. Consequently, it is very important to understand the role of skin 
as a barrier that protects us from environmental contamination and its role in immune 
defence. Immune responses in the skin is the focus in this chapter of research.  
 Skin can be divided into two major layers, the epidermis and dermis (Kaplan., 
2010). Epidermis is derived from ectoderm, mainly composed of keratinocytes and 
Langerhans cells (LCs), which are the only dendritic cells found in this layer during 
steady state (no inflammation) (Kaplan., 2010). In contrast, dermis is a mesoderm-
derived layer, mainly populated by fibroblasts, memory T cells, mast cells and dendritic 
cells (Kaplan., 2010) (Figure 5.1). 
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Figure 5.1 Human skin layers.  
Figure adapted from DermStore.com.2015  https://www.dermstore.com/blog/layers-
and-functions-of-skin/ 
 
Langerhans cells 
 LCs are antigen presenting cells, able to detect pathogens and then mature, 
presenting peptide antigens to T cells in the lymph nodes (Henri et al., 2010). LCs 
survey the epidermal surface with their extended dendrites to search for foreign 
pathogens (Merad et al., 2008). Earlier work suggested that CD207 (langerin) was a 
definitive marker for LCs (Merad et al., 2008). However, recent studies have shown 
there are a number of LC subsets, including CD207+DCs in steady state in central 
lymph nodes, CD207low CD8α+ DCs found in lymphoid tissue and CD11cinter-to-high 
MHCIIhigh phenotype CD207+, originating from skin (Henri et al., 2010). A unique future 
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of LCs are Birbeck granules, identified in 1961, that are intracytoplasmic organelles 
thought to have antimicrobial properties (Merad et al., 2008). Their function is still a 
debate; however, they are thought to be migrating to the periphery of the LCs and 
releasing their contents to the extracellular matrix and/or function as a receptor-
mediated endocytosis (Mc Dermott et al., 2002; Kissenpfennig et al., 2005). 
Langerhans cells express various markers on their surface, such as E-cadherin 
(CDH1), epithelial-cell adhesion molecule (EpCAM), CD205 and CD1a. These are 
responsible for attaching LCs to neighbouring keratinocytes, adhesion, antigen capture 
and processing and antigen presentation to T cells, respectively. Langerhans cells are 
a type of tissue-resident macrophage (Perdiguero and Geissmann., 2016). Epidermal 
LCs have the ability to self-renew and are also maintained by a pool of radioresistant 
proliferating host haematopoietic precursor cells that reside in the skin. Repopulation 
of Langerhans cells in the skin during steady state (without inflammation) occurs very 
slowly in comparison to DC repopulation in the lymph nodes or spleen. However, 
during inflammation (active state), LCs are repopulated by circulating monocytes 
through an M-CSF- dependent pathway (Merad et al., 2008). The LC maturation 
process is not well understood. LCs that recognise microbial antigens secrete pro-
inflammatory cytokines, triggering a wider immune response. According to Merad et 
al. (2008), different methods of isolating LCs (LCs from mouse or human skin isolated 
using enzymatic digestion of skin, or short-term culture of skin pieces) may have a 
different effect on gene expression of Langerhans cells, thus making it difficult to study 
DC maturation. Different gene expression might affect LCs maturation, therefore it can 
dramatically affect the expression of surface markers and consequently their response 
to pathogens.  In vitro studies have shown that LCs isolated from human skin can 
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efficiently activate T helper 1 cells in response to antigen recognition in vitro. They can 
also cross-present (antigen present) them to CD8+ T cells (Merad et al., 2008). 
Dermal dendritic cells 
 Two types of myeloid DCs, spontaneously migrating from skin in situ samples 
have shown overlapping profile of CD14+ DCs with dermal macrophages (Haniffa et 
al., 2015). However, these can be then distinguished by morphology, flow cytometry, 
migratory behaviour, adherence and turnover kinetics. Dermal dendritic cells (dDC) in 
skin play a key role in inflammatory skin diseases. There are two types of dermal DC 
cells that are normally present in the skin, those that reside in skin during the steady 
state and those that are recruited during inflammation, they have a different marker 
expression on their surface (Haniffa et al., 2015). The distribution of human dendritic 
cells, monocytes and macrophages in skin, blood and lymph nodes are shown below 
(Haniffa et al., 2015). 
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Figure 5.2 Distribution of human dendritic cells, monocytes and macrophages 
in skin, blood and lymph nodes.  
Changes during inflammation are indicated in red text. pDC = plasmacytoid DCs, Mac 
= macrophage, mono = monocytes, mo-Mac = monocyte-derived macrophage, inf DC 
= inflammatory DCs, IDEC = inflammatory dendritic epidermal cells, TipDC = TNF 
aplha and iNOS producing DC. Adapted from Haniffa et al., 2015.  
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DCs produce TNFα and iNOS in response to bacterial pathogens (Haniffa et al., 2015).  
The mechanism that controls langerin+ cells activation in skin is not known (Merad, et 
al., 2008).  
 Recent studies have been focused on targeting DCs as a major route of 
vaccination (Macri et al., 2016). Macri et al. (2016) have attempted to understand the 
complexity of the different subsets of DCs to design novel vaccinations based on an 
antigen-conjugated antibody strategy. As the current vaccines are composed of 
pathogen-derived antigens that give rise to antigen-specific memory of B and T cells, 
the DCs (antigen presenting cells), becomes an interesting vaccination target (Macri 
et al., 2016).  
 Chu et al. (2009) have investigated immunoregulatory potential of dermal DC 
and showed that they possess capacity of migration to lymph nodes. Moreover, those 
cells induce regulatory T cells that inhibit skin inflammation. This group has also 
shown, that vitamin D3 up regulated expression of CD141 marker (found on dermal 
DC) in DC derived from blood (that are CD141 negative). They suggest that, this finding 
might be of use to generate cells in vitro, and once transferred in vivo, cells will have 
a capacity of xeno-graft versus host disease and tumor alloimmunity (Chu et al., 2009).  
 Schaeffer, E. et al. (2015) have investigated how dDC impact on the immune 
response to Dengue virus (DENV), using cells isolated from skin tissue by ‘walk-out’.  
Walk-out methods rely on cells leaving the tissue suspended in media. Their findings 
have shown they were unable to detect TNFα production by dDCs in response to 
DENV in comparison to other research (Haniffa et al., 2012) that shown production of 
TNFα by CD1c+ and CD14+ dermal DC. 
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 Here we are investigating if ex-vivo skin tissue sections could provide a suitable 
model for the study of fungal wound infections. Fungal species discussed in this thesis 
are found in the environment. Following traumatic injury, fungal spores are easily being 
introduced into the wound and germinate and spread. The immunology of skin resident 
cells and its interaction with microbes are poorly understood. Therefore, we have an 
taken approach, previously described by some research groups (Haniffa et al., 2015; 
Schaeffer, E. et al., 2015) to investigate interaction of LCs/dDCs, isolated from 
epidermis and dermis ex-vivo skin tissue, with fungal pathogens such as Mucormycete 
and Scedosporium spp.  
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5.2 Materials and Methods 
Unless otherwise stated all reagents were purchased from Sigma Aldrich UK. 
 Strains and growth condition. Strains used in experiments were Rhizopus 
microsporus 12.6652333 (clinical isolate) and Scedosporium apiospermum IHEM 
14462. R. microsporus strain was grown on Sabouraud agar plates (VWR) for at least 
10 days before use. S. apiospermum strain was grown on Potato Glucose agar plates 
for at least 10 days before use. For infection, spore colonies of S. apiospermum 14462 
and R. microsporus were harvested from 2-week-old potato glucose/ sabouraud agar 
(VWR), using PBS and centrifuged at 1000 x g for 3min, maximum breaking and 
acceleration. Spores pellet was resuspended in PBS for counting on haemocytometer.  
 Skin cell isolation from skin off-cuts. Skin samples generated during surgical 
procedures were registered and released via the Human Biomaterials Resource 
Centre (HBRC) in Queen Elizabeth Hospital, Birmingham and then transported in 
DMEM + 100 U/ml of Penicillin- Streptomycin solution on ice (within 1 hour of skin off 
cut) (Figure 5.3 A). After removal of cutaneous fat tissue (by sterile scalpel) (Figure 5.3 
B), 300 μm of epidermis and dermis layers were removed by dermatome (Nouvag) 
following the manufacturers instructions (Figure 5.3 C). Skin layers were cut into 1cm 
square pieces (Figure 5.3 D) and incubated in an enzyme cocktail (1 mg/ml of 
collagenase A (Thermo Fisher Scientific); 0.05 mg/ml of Deoxyribonuclease I from 
bovine pancrease DN25; 2.5 mg/ml of Dispase II, (Thermo Fisher Scientific); RPMI 
1640 (Thermo Fisher Scientific) 10 μl/ml of Penicillin- Streptomycin solution) for 30 min 
at 37° C shaking water bath. Then the epidermis layer was mechanically separated 
from the dermis layer (Figure 5.3 E) and incubated in RPMI1640 (Thermo Fisher 
Scientific) supplemented with 100 U/ml of Penicillin- Streptomycin solution and Human 
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serum from human male AB plasma 10 % for 48 hours in 37° C, humidified, 5% CO2, 
to allow cells to leave the tissue (Figure 5.3 F).  
 
 
 
Figure 5.3 A 
Skin sample was transported in DMEM + 
Pen/Strep solution on ice within 1 hour of skin 
off cut. 
Figure 5.3 B 
Removal of cutaneous fat tissue. 
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Figure 5.3 C 
300 m of epidermis and dermis layers were removed by dermatome. 
Figure 5.3 D 
Skin layers were cut into 1 cm square 
pieces. 
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Figure 5.3 Visualisation of the methodology of steps in skin cells isolation from 
skin off-cut.  
 Skin cell infection with fungal spores and analysis. After 48 hours cells were 
collected from media and centrifuged and then infected with either dead or live spores 
of Rhizopus microsporus 12.6652333 or Scedosporium apiospermum IHEM 14462 
(MOI 10:1) for 5 hours. After 1 hour of infection, 10 ug/ml of Brefeldin A (New England 
Biolabs) was added to samples to stop cytokine release into the media (to enable 
internal markers for TNF-alpha and CD83 detection following infection). After infection, 
Figure 5.3 E 
The epidermis layer was mechanically 
separated from the dermis layer. 
Figure 5.3 F 
Skin cell that left tissue (left) and followed by centrifugation (right). 
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cells were washed with PBS and 10 % heat inactivated rabbit serum (MP Biomedicals) 
was added to cells on ice for 15 min for blocking. Following that, cells were first stained 
for extracellular markers with BV605 mouse anti-human CD11c (BD), PE mouse anti-
human CD45 (BD), PerCP-Cy 5.5 mouse anti-human CD14 (BD), BV421 mouse anti-
human CD141 (BD), BV510 mouse anti-human HLA-DR (BD), PE mouse anti-human 
Langerin CD207 (BD)  (in concentrations suggested by BD supplier, all isotypes IgG) 
antibodies on ice in dark. Following that, cells were washed 3 times in PBS and fixed 
with 1% paraformaldehyde for 10 min in room temperature. Cells were washed with 
PBS then permeabilised with perm/wash buffer (BD) and stained for intracellular 
markers with FITC-conjugated mouse anti-human TNF-alpha (BD) or FITC-conjugated 
mouse anti-human CD83 (BD) antibodies, on ice in dark for 1 hour. Cells were then 
washed 3 times with PBS and analysed by flow cytometry with on an Attune Classic 
instrument with Auto Sampler (Applied Biosystems) to quantify cytokine production.  
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Table 5.1 Mature DC panel.  
Expression of CD83 is a hallmark of DC maturity, can be induced by pro-inflammatory 
cytokines, LPS, CD40 ligands; TNFα cytokine released by keratinocytes play a key 
role in LC migration from epidermis, through dermis to the draining lymph nodes. CD45 
is a marker of hematopoietic cells; HLA-DR is a marker of human leukocyte antigen 
complex; CD11c is a marker of dermal dendritic cells; CD141 is a marker of vascular 
endothelial cells; CD14 is a marker of dermal dendritic cells. All isotypes controls are 
IgG. Flow Cytometry Panel prepared by Dr. Matt Ivory (Cardiff University). Markers 
explanation by Wioleta Trzaska.  
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Table 5.2 Mature LC panel.  
Expression of CD83 is a hallmark of DC maturity, can be induced by pro-inflammatory 
cytokines, LPS, CD40 ligands; TNFα cytokine released by keratinocytes play a key 
role in LC migration from epidermis, through dermis to the draining lymph nodes. HLA-
DR is a marker of human leukocyte antigen complex; CD207 is a marker of Langerhans 
cells. All Isotype controls are IgG. Flow Cytometry Panel prepared by Dr. Matt Ivory 
(Cardiff University). Markers explanation by Wioleta Trzaska.  
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Figure 5.4 Example of flow-cytometry gating on cells isolated from ex-vivo skin 
sheets. First, cells are gated on FSC-A (Forward Scatter Area) /SSC-A (Side Scatter 
Area) for cell size and granularity (A). When cells passes through the laser beams it 
scatter light at all angles (FSC and SSC). FSC is proportional to the cell size, while 
SSC to the internal complexity of the cell. Signals sent by cells are being detected as 
a voltage pulse which is processed and defined by its area (A), height (H) and width 
(W). Height is the intensity of the signal, while area is the height + width; therefore, the 
single cells were gated on FSC-H/FSC-A to separate singlets from doublets and 
clumps (B). Then the gating was on CD45/HLA-DR positive cells to include total dermal 
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DCs (C). Following that, cells were gated on CD141/CD11c (D), where cells of our 
interest were CD141 negative and CD11c positive. Next, cells were analyzed for CD83 
or/and TNF expression (results shown below).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  149 
5.3 Results 
Langerhans cells do not undergo maturation following R. microsporus and S. 
apiospermum infection.  
 Skin is a barrier that protects us from environmental pathogens.  It consists of 
three layers: epidermis, dermis and fat. Langerhans cells (LCs) account for 3-5 % of 
all nucleated cells in epidermis and their primary role is to detect pathogens, at which 
point they mature and migrate to skin-draining lymph nodes to present antigen to T-
cells.  
 To investigate whether LCs undergo maturation and release of cytokines after 
contact with the human pathogens R. microsporus and S. apiospermum, we isolated 
LCs from epidermis and exposed them to spores of both fungal strains. However, upon 
fungal exposure, LCs neither increased expression of CD83 (a well-recognised marker 
of matured dendritic cells (Milne et al., 2015) nor expressed TNFα (a cytokine typ ically 
released by LCs to stimulate T cells). Thus, these preliminary data suggest that LCs 
may not be appropriately triggered to mature and present antigen following contact 
with either of these fungal pathogens ((Figures 5.5 (a, b); 5.6 (a, b); 5.7 (a)). It is 
important, however, to emphasize here that the very limited amount of skin samples 
available, as well as the early stage of this research, mean that these results will need 
independent verification in the future.  
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Figure 5.5 (a) CD83 expression of epidermal cells from “431” skin sample. 
Histograms present untreated cells (I), cells treated with dead spores of R. microsporus 
(II), cells treated with live spores of R. microsporus (II). There is very little maturation 
of Langerhans cells basing on CD83 expression. This figure was analysed by Matt 
Ivory (Cardiff University). 
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Figure 5.5 (b) TNFα expression of epidermal cells from “431” skin sample. 
Histograms present untreated cells (I), cells treated with dead spores of R. microsporus 
(II), and cells treated with live spores of R. microsporus (III). There is no TNFα 
expression at all to fungal pathogen. This figure was analysed by Matt Ivory (Cardiff 
University). 
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Figure 5.6 (a) CD83 expression of epidermal cells from “434” (I) and “435” (II) 
skin samples. 
There is no increased CD83 expression in either of the sample following infection with 
spores of R. microsporus. This figure was analysed by Matt Ivory (Cardiff University). 
Both, Wioleta Trzaska and Matt Ivory undertook this experimental procedure.  
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Figure 5.6 (b) TNFα expression of epidermal cells from “434” (I) and “435” (II) 
skin samples. 
There is no TNFα expression in Langerhans cells following infection with spores of R. 
microsporus in either of the samples. This figure was analysed by Matt Ivory (Cardiff 
University). Both, Wioleta Trzaska and Matt Ivory undertook this experimental 
procedure. 
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Figure 5.7 (a) CD83 and TNFα expression of epidermal cells from “001” skin 
sample. 
There is no epidermal cells recognizable maturation CD83 (I) and no TNFα (II) 
expression following infection with spores of S. apiospermum 14462. 
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Dermal dendritic cells (dDC) undergo maturation followed by contact with R. 
microsporus, but do not release TNFα.  
 Destruction of skin due to an injury provides a route of entry for environmental 
pathogens such as R. microsporus or S. apiospermum. Following exposure to these 
pathogens, we observed that dDCs undergoes maturation (expressing CD83) in 
response to R. microspores but not S. apiospermum.  Despite this, however, these 
activated dDCs did not produce TNFα ((Figures 5.8 (a, b); 5.9 (a, b); 5.7 (b)). Again, 
however, further experiments need to be performed to investigate these observations 
in more detail and, importantly, in other samples.  
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Figure 5.8 (a) CD83 expression of dermal cells from “431” skin sample. 
Histograms present cells treated with dead spores of R. microsporus (I), and cells 
treated with live spores of R. microsporus (II). There is noticeable maturation of dermal 
dendritic cells basing on CD83 expression after both, dead and live spore interaction 
with cells. This figure was analysed by Matt Ivory (Cardiff University). 
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Figure 5.8 (b) TNFα expression of dermal cells from “431” skin sample. 
Top histograms present cells treated with dead spores of R. microsporus (I), and cells 
treated with live spores of R. microsporus (II). There is no TNFα expression in cells 
treated with dead/live spores. This figure was analysed by Matt Ivory (Cardiff 
University). 
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Figure 5.9 (a) CD83 expression of dermal cells from “434” (I) and “435” (II) skin 
samples. 
There is recognizable maturation of dermal dendritic cells in both of the samples 
following infection with both, live and dead spores of R. microsporus. This figure was 
analysed by Matt Ivory (Cardiff University). Both, Wioleta Trzaska and Matt Ivory 
undertook this experimental procedure. 
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Figure 5.9 (b) TNFα expression of dermal cells from “434” (I) and “435” (II) skin 
samples. 
There is no recognizable TNFα expression in dermal dendritic cells in both of the 
samples following infection with both, live and dead spores of R. microsporus. This 
figure was analysed by Matt Ivory (Cardiff University). Both, Wioleta Trzaska and Matt 
Ivory undertook this experimental procedure. 
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Figure 5.7 (b) CD83 and TNFα expression of dermal dendritic cells from “001” 
skin sample. 
There is no dermal dendritic cells recognizable maturation CD83 (I) and no TNFα (II) 
expression following infection with spores of S. apiospermum 14462. 
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5.4 Discussion 
 The biggest organ of the human body, skin, is an excellent barrier to protect us 
from environmental pathogens as well as microbes resident on the skin. Apart from its 
mechanically protective role, it is equipped with a complex system of immune cells. 
 Dendritic cells residing in the epidermis, called Langerhans cells, are critical 
antigen-presenting cells that penetrate the epidermal layer, searching for pathogens 
and then present them to T cells. Going deeper into the skin, in the dermal layer, the 
immune system relies on dermal dendritic cells. Those, similar to LCs, undergo 
maturation after recognition of pathogen and migrate through the dermal lymphatic 
vessels to skin-draining lymph nodes to localize T cells. An important point to mention 
is that LCs may mediate tolerance whereas dDCs are thought of as more 
proinflammatory (Mutyambizi et al., 2009).  
 Here we present preliminary data on developing a novel model to investigate 
host-pathogen interaction using ex-vivo skin off cuts. This is a promising model for two 
reasons; first, to provide a source of isolated epidermal and dermal cells for in vitro 
study and second, to provide a model to observe skin penetration by pathogens. At 
this stage, the data presented here are very preliminary, since acquisition of human 
samples proved challenging.  However, these preliminary data demonstrate feasibility 
and highlight some interesting (albeit n=1) observations, such as the specificity of dDC 
maturation in response to R. microsporus.  Future development of this model will, we 
hope, offer useful insights into the role of skin immune function in protecting against 
trauma associated fungal infection. Pearton et al. (2010) have shown ex-vivo skin 
model as a valuable model to observe LCs morphological changes following ID 
(intradermal) injection of H1 VLP (influenza virus-like particle) vaccine. Their results in 
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ex-vivo skin model (human environment) confirmed previous observations in animal 
model. Similarly, research done by Ivory et al. (2015) and Schaeffer et al. (2015) also 
using ex-vivo skin model to investigate LCs response to dengue virus (DENV) have 
shown skin-resident immune cells increasing inflammatory response to DENV 
infection. Czubala et al. (2016) has also investigated LCs (isolated from epidermis), 
interaction with HIV-1 from the same model and showed ability of LCs to decrease 
post-entry activity of HIV-1. 
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6. Conclusions 
6.1. Novel approaches to treat trauma-associated fungal infections 
 Traumatic injuries, caused by man-made accidents, environmental disasters or 
those acquired during combat, can result in serious infections leading to high morbidity 
and mortality. Fungal spores, the point of interest of this research, are typically 
introduced into a wound during injury, where the available nutrients, together with a 
moist and warm environment, provides the ideal ecosystem for their growth. All fungal 
species tested in this research, such as Mucormycetes, Scedosporium, 
Lomentospora, Fusarium and Cryptococcus are ubiquitous environmental fungi, with 
a wide-range of antifungal resistance profiles and global incidence. Diagnosis is very 
often delayed; the need for specimen collection and investigation requires time (in 
military field hospitals taking up to 10 days). These limitations often result in aggressive 
surgical debridement as a precautionary measure, resulting in disability and 
amputations. Moreover, the cost of treating invasive fungal infections is extremely high.  
 Therefore, here we have investigated how two novel treatments; acetic acid and 
blue light, are effective against fungal species causing wound infections.  
 
Acetic acid.  
 We have demonstrated that low concentrations of acetic acid can inhibit spore 
germination of Mucormycetes, Scedosporium, Lomentospora and Fusarium spp. as 
well as preventing growth of Candida and Cryptococcus spp. Indicating that acetic acid 
can be used as a potential treatment; for example, as a wound topical agent or dressing 
at the time of the injury, such as in field hospitals, where appropriate diagnosis and 
treatments are very often delayed. We have also shown that low concentrations of 
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acetic acid inhibit further growth of germinated conidia, indicating that this drug can 
also be suitable for disease treatment even if infections have already established. 
 Moreover, this pattern was conserved across different fungal species tested, in 
comparison to other currently used antifungals, for example, commonly used hydrogen 
peroxide, which has been shown to be ineffective in reducing growth of different 
microbes (Drosou. A and Kirsner. R, 2003). Our findings are equivalent to the recent 
findings of Halstead et al. (2015), and others, who have shown antimicrobial properties 
of acetic acid to burn wound infection bacterial pathogens such as P. aeruginosa, A. 
baumannii, E. coli, K. pneumoniae, E. cloacae, P. mirabilis and MRSA (Entani et al., 
1998; Ryssel al., 2009; Halstead et al., 2015). Therefore, acetic acid presents a 
powerful therapeutic agent, for both bacterial and fungal pathogens. Additionally, as 
shown by Fraise et al. (2013) it is a stable treatment that is not affected by evaporation 
nor by inactivation by cotton swabs, therefore is an ideal dressing drug for a wound 
infection.  
 Despite the long-time debate regarding the mechanism of action of acetic acid 
this remains unsolved. We have been able to light up the direction of further 
investigation into this subject by showing that the activity of acetic acid is not due to its 
low pH, but a combination of both hydrogen ions and accumulation of acetate within 
the fungal cell. Previous studies by Levine and Fellers (1940) have also shown that 
the acetic acid inhibitory effect is not due to a low pH, and also more recent research 
of Roe et al. (2002) who investigated acetic acid inhibitory effect of E. coli, have shown 
that this effect is a result of either reduction of pH or intracellular accumulation of 
acetate anion. Their research suggest that acetate inhibits the methionine biosynthesis 
pathway, which leads to the accumulation of homocysteine that has an inhibitory effect 
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to the cell (Roe et al., 2002). Also, Cottier et al. (2015 a, b) have shown transcriptional 
responses and MIG1 gene involvement in the mechanism of action of weak acids as 
well as iron uptake involvement (Mira et al., 2010; Cottier et al., 2015 a, b). All this 
research suggests that the mechanism of action of acetic acid is multifactorial and it 
might depend on different factors such as, lowering intracellular pH, acetate 
accumulation within cell, gene up/down regulation, ion transport etc… (Hirshfield, 
Terzulli & O’Byrne., 2003). 
 Results obtained in this study highlight a great potential of acetic acid antifungal 
abilities to treat trauma-associated fungal infections, however this research holds a few 
limitations. First, the limited number of acids (lactic and hydrochloric acids) comparison 
to the activity of acetic acid itself, especially an organic acids such as citric, propionic, 
fumaric, sorbic or benzoic acids which are often of an interest of antimicrobial study 
(Hirshfield, Terzulli & O’Byrne., 2003). Second, a lack of investigation of potential 
acetic acid resistance that could be developed by the fungal species tested. It has been 
previously shown that E. coli and Salmonella have adapted to organic acids 
antimicrobial properties (Guilfoyle & Hirshfield., 1996; Kwon & Ricke., 1998). 
Therefore; a possibility of adaptation and/or resistance development to acetic acid 
should be investigated in fungal species used in this research. Third, we have shown 
that acetic acid is fungistatic and fungicidal against planktonic ungerminated and 
germinated cells/spores, but the activity of this acid has not been tested against fungal 
biofilms. It is well known that many fungal species including 
Scedosporium/Lomentospora spp., Mucormycetes spp. and Fusarium spp. can form 
biofilm (Mello et al., 2016; Singh, Shivaprakash & Chakrabarti., 2011; Peiqian et al., 
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2014). Therefore; acetic acid activity should be tested on biofilms formed by those 
fungal species, its fungistatic/fungicidal concentration, stability and persistence.  
 In the future, it would be of benefit to explore in more depth the molecular 
mechanism of action of acetic acid. One of the approaches basing on our current 
results and observations (showing that acetic acid antifungal activity is a function of 
both undissociated acid and/or free acetate, together with the reduced pH driven by 
the dissociated hydrogen ions) would be to investigate fungal proton pump response 
to acetic acid. As this is an essential for intracellular pH regulation and maintenance of 
nutrient uptake, investigation of how acetic acid negatively affects its role could be an 
important point for understanding the antimicrobial assets of this acid. Two, main 
proton pumps involved in fungal pH control are V-ATPases and P-type proton pump 
Pma1 (Kane., 2016). Investigation of genetic regulation of those proton pumps during 
exposure to acetic acid could help identify target genes that are involved in up/down 
regulation of activity of proton pumps during such a treatment. This could help us 
develop novel drugs that would have a mechanism of action similar to powerful acetic 
acid that could be potentially used intravenously, not just topical as acetic acid is at the 
moment. Or/and identify how acetic acid could be designed to be used as 
oral/intravenous agent antifungal drug. 
 
Blue light.  
 We have shown that blue light irradiation is effective against some but not all 
fungal species tested. These results are similar to those presented by Moorhead al. 
(2016), who investigated antifungal activity of blue light (405 nm) radiation on 
microcondia of Trichophyton spp. and Aspergillus niger. They showed that 
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microconidia of T. rubrum are much more sensitive to BL irradiation than the conidia 
of A. niger, so therefore species-specific activity of blue light (Moorhead et al., 2016). 
 We have also shown that blue light antifungal treatment was species-specific 
when treatment was applied on ungerminated spores/cells, but effective across all 
species when applied on germinated spores/cells. These results are similar to those 
presented by De Lucca et al. (2012) who have also shown that blue light treatment 
(20-100 J/ cm2) of ungerminated conidia of Penicillium digitatum is ineffective, 
however; they have noticed approximately 80-98 % viability losses when blue light 
treatment (40-100 J/ cm2) was applied on germinated conidia on this strain. A similar 
pattern was observed for Fusarium graminearum when blue light treatment was 
ineffective against ungerminated conidia, but effective on germinated ones (De Lucca 
et al., 2012). A difference between our studies was the amount of blue light delivered 
to fungal spores, we have treated the spores for 60 min which was equivalent to a dose 
of 216 J/ cm2, while De Lucca et al. (2012) has applied blue light treatment with dose 
of 20-100 J/ cm2. So, even with the higher dose provided by us caused no change in 
pattern of antifungal activity. Similar, species-specific result are found in bacteria and 
bacterial biofilms formation treatment of blue light. Halstead et al. (2016) have shown 
that Gram positive biofilms were less sensitive to blue light treatment then Gram 
negative biofilms. However, the authors conclude that despite variability of results 
between different bacterial isolates, overall results demonstrated blue light 
antimicrobial potential and decreased bacterial viability following treatment (Halstead 
et al., 2016).  
 Moreover, for the first time we showed that blue light induces morphological 
changes in R. microspores. It has been shown previously in one of the case study, that 
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Mucor circinelloides has been isolated from blood of immunosuppressed patient and 
was able to convert into yeast forms under anaerobic conditions (Arroyo et al., 2016). 
This phenomenon or ability of switching morphology is not understood so it might have 
immunological consequences that should be investigated further. As morphology has 
been shown in other fungi to have a major role in pathogenicity and virulence (Boyce 
& Andrianopoulos., 2015; Gauthier, 2017; Dambuza. et al., 2018). In our research, 
treating spores of different fungal species with blue light (BL), we have shown that this 
approach cannot be used as a prevention of a disease nor as a surface cleaner in the 
context of fungal pathogens. As blue light is already in use in many clinical settings, 
this research highlights both the advantages as well as potential risk of using such an 
approach.  
 Despite those interesting findings, we have faced a few pitfalls such as 
secondary heat generation and morphology switch in Mucormycetes spp. This study 
could be extended into a few additional experiments. One of those would be testing 
blue light activity against fungal species (Mucormycetes, Fusarium, 
Scedosporium/Lomentospora and Candida spp.) over time, to assess their 
susceptibility/resistance to regular treatment which could possibly be more effective 
than one dose treatment. This approach is being taken in terms of using blue light 
treatment for Propionibacterium acne causing facial acne. Gold et al. (2009) have 
presented study of treatment of mild-to-moderate inflammatory acne over the period 
of eight weeks on 21 volunteers. Their study showed that self-treatment using blue 
light device have reduced the number of inflammatory acne lesion significantly. This 
reduction was observed in time, more treatment, less blackheads and whiteheads 
appearance; skin irritation has also improved following treatment; sign of inflammation 
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have reduced in time too (Gold et al., 2009). Therefore, using a blue light device to 
treat trauma associated fungal species while they are still in spore/cell stage 
(ungerminated) would be interesting to investigate whether longer exposure/ more 
regular treatment to this light could have a more effective antifungal effect. Saying that, 
this approach would also be beneficial in terms of investigation of fungal adaptation/ 
resistance development. Long-term exposure would help us answer both questions; 
possible better antifungal efficiency but also, a possible fungal adaptation to this 
treatment. Another limitation of this study, a tactic to extend the research, would be 
cytotoxicity testing on epithelial/skin cells. There has been some research that present 
blue light not cause DNA damage nor early photo-ageing (Kleinpenning et al., 2010). 
Their research on healthy volunteers over time of 5 days have also shown that blue 
light irradiation caused transient melanogenesis and inexplicable vacuolization without 
resulting apoptosis (Kleinpenning et al., 2010). Similarly, research by Zhang et al. 
(2014) have shown that irradiation by blue light caused almost no apoptotic cells in 
epidermis. However, those researches have not been investigated on wound damaged 
skin, therefore this approach, using ex-vivo skin model together with blue light could 
bring a new set of data that would give us more knowledge of potential blue light 
treatment of trauma-associated fungal infections.  
 Future prospective for this project could involve an investigation of its molecular 
mechanism, which would be beneficial to answer why some fungal species are more 
susceptible to this treatment than others and potentially how this strategy may be 
improved. Our results suggest that one of the mechanisms involved in antifungal 
efficiency of BL could involve melanin presence/absence in fungal cell wall. It is well 
known that melanin plays an important role in fungus protection from extreme 
  170 
environmental conditions but also is involved in virulence (Gessler, Egorova & 
Belozerskaia., 2014). A. fumigatus, for example, uses melanin to inhibit 
phagolysosome acidification and to protect itself from UV (Geib et al., 2016). L. 
prolificans it has been shown to use melanin to protect itself from UV, H2O2 but not 
ampB (Al-Laaeiby et al., 2016). It is also known that cell wall of many fungal species 
changes during germination, for example Mucor of Mucormycetes spp. melanin 
content is different between conidial cell wall and hyphae, for example (Orlowski, 
1991). That could be an explanation for different susceptibility of those species to blue 
light treatment. But this requires further investigation. 
6.2 Investigation of host-pathogen interactions 
 Our understanding of how fungal pathogens interact with host innate immune 
cells and how they manipulate those cells is still very limited, despite many years of 
research. In particular, some of the species associated with traumatic injuries, such as 
Scedosporium and Lomentospora spp., are very understudied.  
 
Scedosporium and Lomentospora spp. interaction with the host innate immune 
system.  
 Here we have investigated how highly pathogenic and antifungal resistant 
species of Scedosporium and Lomentospora interact with innate immune cells. We 
have shown that both S. apiospermum and L. prolificans are well phagocytosed by a 
range of different macrophages; including the murine macrophage cell line J774A.1, 
primary cells such as HMDMs, and iPSC- derived macrophages.  These results are 
similar to Xisto et al. (2016) who have also shown, that L. prolificans is being well 
phagocytosed by murine macrophages. They have shown that O-linked 
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oligosaccharides are involved in recognition, uptake and pro-inflammatory cytokine 
production by macrophages when in contact with L. prolificans (Xisto et al., 2016). Gil-
Lamaignere et al. (2003) have also shown that S. apiospermum is being well 
phagocyted by monocyte-derived macrophages. They have presented in their 
research, in between, that serum opsonisation of hyphae had higher level of 
superoxide anion (O2-) release by human polymorphonuclear leukocytes (Gil-
Lamaignere et al., 2003). We have, in fact, not investigated how serum opsonisation 
influence hyphal damage to compare to their results, but we have research whether 
serum opsonisation will influence fungal spore survival within macrophages, and we 
found no difference in survival when compared to control (non-opsonised). The answer 
to why serum opsonisation had no influence of fungal survival remain unknown, 
however we could assume/propose further investigation on complement receptors that 
are potentially not involved in phagocytic uptake or/and fungal survival within 
macrophages, and signalling pathways involved in this process.     In all cases, 
however, the fungi are able to survive and then subsequently germinate, penetrate and 
kill the macrophage. We have also shown that live spores of S. apiospermum and L. 
prolificans manipulate J774A.1 by preventing acidification of the macrophage 
phagosome. The question of what approach those fungal species take to do so remain 
unanswered at the moment by us as well as other research groups.  One striking 
finding is that L. prolificans is consistently better at germinating within macrophages 
than S. apiospermum. These results were no surprise to us as it has been previously 
shown that L. prolificans have higher germination rate generally, and within innate 
immune cells than Scedosporium spp. (Melloet al., 2018; Rollin-Pinheiro et al., 2017). 
Moreover, for the first time, we have shown that vomocytosis and lateral transfer are 
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two distinct events by the observation that Scedosporium and Lomentospora spp. 
appear unable to vomocytose and yet still undergo lateral transfer.  
 During investigation of Scedosporium and Lomentospora spp. interaction with 
macrophages we met a few pitfalls. The main one was a lack of time to investigate 
some of the matters in detail. These are signalling pathways involved in spore survival 
within macrophages that could have been involved in either: serum opsonisation 
results that we have gained, or ability of spore to manipulate acidification by 
phagosome to unable fungal survival. We have also only touched on the investigation 
of events such as vomocytosis and lateral transfer in both, Scedosporium and 
Lomentospora spp. All of those mentioned above are complex behaviours that requires 
many experimental approaches to be able to seek an answer to potential explanation 
and requires to be investigated further. 
 Based on this research, one of the most interesting results worth further 
investigation is the mechanism of action behind lateral transfer and vomocytosis. 
However, we now know that some fungi are able to escape from the phagocyte and 
evade killing by two processes, non-lytic expulsion (vomocytosis) and cell-cell transfer 
(lateral transfer). Despite the discovery of these processes over 10 years ago (Ma at 
al., 2006; Ma et al., 2007; Al-Laaeiby et al., 2016), the driver(s) behind and reason(s) 
for the existence of these mechanisms of escape are largely unknown. In the past, 
vomocytosis has been described as unsuccessful lateral transfer where the phagocyte 
fails to pass the fungus to another phagocytic cell (Ma at al., 2006). Because 
Scedosporium and Lomentospora spp. are first to be known fungal pathogens that are 
able to perform one (lateral transfer) but not the other, are a great model to investigate 
those two events as a separate incidents. This preliminary data shows macrophages 
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infected with Scedosporium and Lomentospora or Cryptococcus spp. act cell to cell 
differently. There were no vomocytosis events when macrophages are infected with 
either Scedosporium or Lomentospora spp. However, there were recurring events of 
lateral transfer. More interestingly, spore transferred to another macrophage was either 
killed in the recipient macrophage or germinated. Moreover, macrophages that transfer 
a spore to another macrophage was not necessarily necrotic.  
Future research would also address how these uncharacterized fungi interact with the 
innate immune system, and provide answers regarding the driving force behind lateral 
transfer and vomocytosis. This increased knowledge could be exploited in subsequent 
applications to develop novel approaches to tackling fungal infections. 
 
Ex-vivo skin model.  
 The second part of this host-pathogen investigation in this project was to 
develop a novel ex-vivo skin model. As breached skin is the first organ that comes into 
contact with environmental pathogens at wound sites, an investigation of how skin 
immune cells interact with fungi is important for determining the host response to 
traumatic infection. Both skin layers, epidermis and dermis, are equipped with antigen 
presenting cells who undergo maturation after pathogen recognition, and present 
pathogen antigen to T cells. However, it remains unknown how the cells in these two 
layers respond to R. microsporus and S. apiospermum. 
 Therefore, here we investigated if both Langerhans cells (cells of the epidermis) 
and dermal dendritic cells (dermal cells) are able to recognise fungal pathogens, 
undergo maturation and release cytokines. We have chosen to investigate CD83 
marker, a maturation marker of dendritic cells, and TNFα, a cytokine released by DCs 
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to stimulate T cells. Our results are very limited due to the very early stage of this study.  
However, it appears that LCs do not mature or release TNFα following infection with 
R. microsporus and S. apiospermum. One explanation for this finding is that LCs are 
found in the top layer of the skin and thus might contact environmental pathogens on 
a regular basis and therefore should show tolerance towards them.  These results may 
be equivalent to other researcher’s investigation on LCs tolerogenic role (Mutyambizi, 
Berger & Edelson., 2009; Shklovskaya et al., 2011; Kitashima et al., 2018).  However, 
dDC do recognise R. microsporus, but not S. apiospermum (n of 1), and undergo 
maturation but interestingly do not appear to release detectable TNFα, a finding which, 
if reproducible, would hold significant clinical implications. Ex-vivo skin model, however 
recently appear more often in research, especially in investigation of viral 
infections/entry to our body (Schaeffer et al., 2015; Czubala et al., 2016) is still not well 
understood and very complex. More research on skin cells subsets as well as its 
interaction with a variety of different pathogens, such as fungal species whose are 
being in contact with traumatic wound, will help us to gain more knowledge about those 
cells that are very often first contact with environmental pathogens on a daily basis. 
 As mentioned above, this model is at a very early stage of study. During this 
study we met an issue with obtaining skin samples. Due to this, we cannot base any 
conclusions gained from our results, however we can propose this model as a valuable 
ex-vivo model to investigate host-pathogen interaction. 
  Future investigation, if more skin samples was be provided, would be to take 
dual approaches. First, to continue investigate LCs and dDCs, isolated from skin 
sheets, interaction with fungal pathogens, with extension to explore different cytokines 
that are potentially released from immune cells in contact with fungal pathogens, as 
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well as investigate more trauma associated fungal species. Second approach would 
be to use ex-vivo skin off cuts as a model to investigate how fungal pathogens 
penetrate skin using biopsy methods. This method would allow as seeing how immune 
cells gathering (or not) around the pathogen and migrating down to present antigens 
to T cells. Moreover, this approach would help us to answer some question and link to 
previous research questions/topics we raised in this PhD project. Those would be to 
use skin sheet samples to infect with fungal spores and investigate how acetic acid 
can be used as a topical treatment/wound dressing and to compare its antifungal 
activity to in-vitro results that we have obtained. We would extend the methodology 
into using histopathology to observe changes in skin cells following contact with fungal 
pathogens, similar approach to that taken by Pearton et al. (2010). This observation 
would give us an idea of antifungal activity of acetic acid, penetration of drug through 
the wounded vs none wounded skin and the cytotoxicity on intact and wounded skin. 
Then, we would investigate the antifungal potential of blue light. Similarly, to acetic 
acid proposed approach, we would investigate if and how deep blue light penetrate 
skin samples infected with fungal spores. Its toxicity on wounded vs unwounded skin 
samples following multi-time treatment and possible combination of low concentration 
of acetic acid and BL treatment.  
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7. THESIS SUMMARY 
 This Thesis has been focused on investigation of novel treatments for fungal 
infections associated with traumatic injuries and understanding the host interaction 
with one of those, very understudied fungal species, Scedosporium and 
Lomentospora. The data in this thesis highlights great antifungal activity of acetic acid 
against different fungal species tested. The blue light approach is associated with more 
challenges, because my data suggest that it can have both positive and negative 
impacts on patient outcome, depending on the infecting species. This requires proper 
diagnosis prior to treatment. This research also shield light on lateral transfer and 
vomocytosis events to be separate mechanisms, shown here for the first time, during 
investigation of Scedosporium and Lomentospora spp. with macrophages. Finally, this 
research also introduce into ex-vivo skin model as a potential model to investigate skin-
fungal interaction. 
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